Structural Characterization of the Integrin Αiibβ3 Transmembrane and Cytosolic Domains by Metcalf, Douglas G
University of Pennsylvania
ScholarlyCommons
Publicly Accessible Penn Dissertations
Summer 8-14-2009
Structural Characterization of the Integrin Αiibβ3
Transmembrane and Cytosolic Domains
Douglas G. Metcalf
University of Pennsylvania, doug.metcalf@gmail.com
Follow this and additional works at: http://repository.upenn.edu/edissertations
Part of the Amino Acids, Peptides, and Proteins Commons, Biochemistry, Biophysics, and
Structural Biology Commons, and the Oncology Commons
This paper is posted at ScholarlyCommons. http://repository.upenn.edu/edissertations/23
For more information, please contact libraryrepository@pobox.upenn.edu.
Recommended Citation
Metcalf, Douglas G., "Structural Characterization of the Integrin Αiibβ3 Transmembrane and Cytosolic Domains" (2009). Publicly
Accessible Penn Dissertations. 23.
http://repository.upenn.edu/edissertations/23
Structural Characterization of the Integrin Αiibβ3 Transmembrane and
Cytosolic Domains
Abstract
Integrin’s are the principal cell surface receptors that link the cytoskeleton to the extracellular matrix. They
exist in active conformations that can bind extracellular ligands and resting conformations that cannot. The
platelet integrin αIIbβ3 is a prototypical regulated integrin that is resting on a circulating platelet and becomes
activated to adhere the platelet to the vascular endothelium or subendothelial matrix.
The integrin is composed of α and β subunits and each subunit contains a single transmembrane helix that
form an α/β heterodimer in the resting state. Additionally, each subunit contains a cytosolic domain that
binds signaling proteins that affect the resting-active equilibrium. Activation signals are transduced across the
membrane by separating the transmembrane heterodimer.
The structure of the resting integrin αIIbβ3’s transmembrane and cytosolic domains was characterized by
molecular modeling and NMR spectroscopy. First, software was developed to model transmembrane helix
dimers using experimental mutagenesis results as a modeling restraint. Next, the αIIb/β3 transmembrane
heterodimer was modeled and the model was compared to published experimental data and other published
models. The model correlated well with experimental findings and converged on the same structure as other
top performing models, suggesting this conformation approximates the native interface. The model’s interface
includes αIIb residue Met987 and β3 residue Leu712. These residues were mutated to cysteine to crosslink
peptides corresponding to the αIIb and β3 cytosolic tails, and the disulfide-linked construct was probed by
NMR spectroscopy.
NMR revealed that the αIIb and β3 cytosolic tails have a dynamic interface. The αIIb subunit is natively
unstructured and the β3 subunit consists of a hydrophobic helix followed by two amphiphilic helices. The
amphiphilic portions of β3 include domains that interact with cytosolic proteins, but the membrane
embedding of its hydrophobic faces sequesters some of the interacting residues. This result suggests that the
integrin’s resting-active equilibrium is coupled to an equilibrium between membrane embedded and solvent
exposed conformations of the β3 cytosolic tail, providing new insight into integrin activation.
Degree Type
Dissertation
Degree Name
Doctor of Philosophy (PhD)
Graduate Group
Biochemistry & Molecular Biophysics
First Advisor
William F. DeGrado
This dissertation is available at ScholarlyCommons: http://repository.upenn.edu/edissertations/23
Keywords
integrin, aIIbb3, transmembrane, molecular modeling, NMR
Subject Categories
Amino Acids, Peptides, and Proteins | Biochemistry, Biophysics, and Structural Biology | Oncology
This dissertation is available at ScholarlyCommons: http://repository.upenn.edu/edissertations/23

ii 
 
 
 
 
 
 
 
 
dedicated to: 
My Mom and Dad, Kathy and Doug Metcalf 
 
iii 
 
ABSTRACT 
 
STRUCTURAL CHARACTERIZATION OF THE INTEGRIN αIIbβ3 
TRANSMEMBRANE AND CYTOSOLIC DOMAINS 
Douglas G. Metcalf 
 
William F. DeGrado 
Integrin’s are the principal cell surface receptors that link the cytoskeleton to the 
extracellular matrix.  They exist in active conformations that can bind extracellular 
ligands and resting conformations that cannot.  The platelet integrin αIIbβ3 is a 
prototypical regulated integrin that is resting on a circulating platelet and 
becomes activated to adhere the platelet to the vascular endothelium or 
subendothelial matrix. 
The integrin is composed of α and β subunits and each subunit contains a 
single transmembrane helix that form an α/β heterodimer in the resting state.  
Additionally, each subunit contains a cytosolic domain that binds signaling 
proteins that affect the resting-active equilibrium.  Activation signals are 
transduced across the membrane by separating the transmembrane heterodimer. 
The structure of the resting integrin αIIbβ3’s transmembrane and cytosolic 
domains was characterized by molecular modeling and NMR spectroscopy.  
First, software was developed to model transmembrane helix dimers using 
iv 
experimental mutagenesis results as a modeling restraint.  Next, the αIIb/β3 
transmembrane heterodimer was modeled and the model was compared to 
published experimental data and other published models.  The model correlated 
well with experimental findings and converged on the same structure as other top 
performing models, suggesting this conformation approximates the native 
interface.  The model’s interface includes αIIb residue Met987 and β3 residue 
Leu712.  These residues were mutated to cysteine to crosslink peptides 
corresponding to the αIIb and β3 cytosolic tails, and the disulfide-linked construct 
was probed by NMR spectroscopy. 
NMR revealed that the αIIb and β3 cytosolic tails have a dynamic 
interface.  The αIIb subunit is natively unstructured and the β3 subunit consists of 
a hydrophobic helix followed by two amphiphilic helices.  The amphiphilic 
portions of β3 include domains that interact with cytosolic proteins, but the 
membrane embedding of its hydrophobic faces sequesters some of the 
interacting residues.  This result suggests that the integrin’s resting-active 
equilibrium is coupled to an equilibrium between membrane embedded and 
solvent exposed conformations of the β3 cytosolic tail, providing new insight into 
integrin activation.  
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CHAPTER 1 
 
Background on Integrins and 
Methods to Define Their Three-Dimensional Structure 
 
INTRODUCTION 
Integrins are cell surface receptors that enable cell-cell and cell-matrix 
interactions by engaging extracellular molecules.  Integrin-ligand binding events 
mediate cell adhesion and migration and initiate intracellular signaling pathways 
that regulate key processes such as proliferation, differentiation, and apoptosis.1  
Thus it is not surprising that integrins play pivotal roles in health and disease.  
For example, they are targeted by snake venoms, including rattlesnake and 
cottonmouth venoms that can cause hemorrhage and occasionally death.2  
Additionally, viruses including adenovirus, rotavirus, hantavirus, and HIV 
recognize integrins to penetrate and hijack cells.3  In the research and clinical 
setting, integrins serve as biomarkers to distinguish different cell types and 
they’re used for diagnostics to characterize pathological states.4  Also, various 
pharmaceuticals target integrins in approved treatments for multiple sclerosis, 
Crohn’s disease, and certain coronary events (TysabriTM  generated $589 million 
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in revenue for 2008),5; 6 and integrin antagonists are being developed as 
therapeutics for other conditions such as cardiovascular disease and cancer, the 
number 1 and 2 leading causes of death in America.6; 7; 8  Thus integrin structure 
and function is an intriguing and important field of study in biology and medicine. 
Integrins are transmembrane (TM) glycoproteins composed of α and β 
subunits.  In mammals, there are 18 different α subunits and 8 different β 
subunits that form 24 known α/β pairs through a heterodimeric interaction in their 
extracellular domains.1  Each integrin subunit is a type 1 membrane protein that 
also contains a single TM helix and a cytosolic carboxy-terminus.  The plasma 
membrane contains α/β heterodimers that exist in an equilibrium between resting 
conformations that have low affinity for extracellular ligands and active 
conformations that have high affinity.9  Signaling cascades that shift the integrin 
equilibrium toward the active state, termed “inside-out” signals, have received 
significant attention over the past few decades, including the recent identification 
of the cytoskelatal proteins talin and kindlin as essential mediators of integrin 
activation.10; 11  These molecules are postulated to bind the integrin’s cytosolic 
domains and disrupt a heterodimeric α/β interaction in the TM region.  Separation 
of the resting integrin’s α/β TM heterodimer functions to transduce an activation 
signal across the membrane, ultimately causing a conformational change that 
exposes the integrin’s extracellular ligand binding sites.12  Once an integrin is 
activated, it can initiate “outside-in” signals and recruit additional proteins to form 
large structural and signaling complexes such as focal adhesions that tightly bind 
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the underlying actin cytoskeleton.13  The goal of the research presented here is to 
test hypotheses that suggest mechanisms for integrin activation by defining the 
three-dimensional structure of the resting integrin’s TM and cytosolic domains. 
Three-dimensional models of protein structure are invaluable research 
tools because they provide paradigms to predict and validate experimental 
results, and their importance is underscored by the $765 million Protein Structure 
Initiative.14  For integrins, three-dimensional structures of the extracellular domain 
in “bent” and “extended” conformations led to several testable hypotheses that 
suggest different mechanisms for integrin activation.15; 16; 17  Additionally, models 
of the integrin’s TM and cytosolic domains have been developed, however until 
recently, they provided marginal insight into integrin function because they did 
not make useful predictions or spur further analysis. 
This thesis describes and authenticates a model of the resting TM 
heterodimer for the αIIbβ3 integrin that aided in the engineering of a disulfide-
linked αIIb/β3 cytosolic domain.  The model was calculated using a recently-
developed Monte Carlo algorithm that includes a selective advantage for 
conformations that are consistent with experimental mutagenesis results, and 
this software is benchmarked and validated in chapter 2.  The Monte Carlo model 
was subsequently confirmed by measuring several of its attributes and 
correlating them with published experimental results using other published 
models as controls, and chapter 3 presents this analysis.  Correlations with 
cysteine crosslinking experiments were of particular interest because they 
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identified αIIb/β3 cysteine mutant pairs at the model’s heterodimer interface that 
could covalently crosslink the αIIb and β3 subunits.18  Based on this finding, 
cysteines were positioned to enforce the model’s TM heterodimer interface in a 
construct consisting of the αIIb and β3 cytosolic domains tethered by a disulfide 
bond.  This construct was expressed, purified, and then probed by NMR 
spectroscopy, enabling the calculation of a solution structure for the β3 subunit 
described in chapter 4.  The subsequent structural analysis makes several 
predictions that weren’t apparent a priori.  Notably much of the β3 cytosolic 
domain is pre-organized into conformations that are similar to structures depicted 
in β3/talin interfaces,19; 20 thereby minimizing the entropic cost of binding, however 
these regions are calculated to partition into the plasma membrane and an 
interaction with talin would trap β3 in an alternate, exposed conformation, 
providing a mechanism for talin-induced conformational change.  Further 
implications of the NMR structure and future directions are discussed in chapters 
4 and 5.  
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CHAPTER 2 
 
Development of Software to Model the Integrin 
αIIb/β3 Transmembrane Heterodimer 
 
INTRODUCTION 
The prediction of membrane protein structure is a particularly important endeavor 
given the relative difficulty of determining structures experimentally.  Despite 
impressive progress in the development of force fields and energy scoring 
functions,1; 2; 3; 4 current modeling protocols cannot reliably identify the native 
conformation of most membrane proteins without additional information from 
experimental analysis.  Successful protocols exploit information derived from 
sequence analysis,5; 6; 7; 8; 9; 10 spectroscopy,5; 8; 9; 11; 12; 13; 14 cross-linking,8; 11; 12 and/or 
mutagenesis,8; 15; 16 or the known structures of homologous17 or non-homologous 
proteins.1 
Brunger and coworkers developed a conformational searching algorithm to 
predict membrane helix oligomers, and this protocol has been applied to 
glycophorin A,15; 18 phospholamban,19 the M2 and CM2 proton channels in the 
influenza A and C viruses,20 and the vpu protein from HIV-1.20  In this protocol, 
conformational space is searched exhaustively and then low energy structures 
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are screened to identify conformations that are most consistent with experimental 
findings, frequently mutagenesis results.  Alternatively, orthologous or 
homologous proteins can be modeled in parallel and the native conformation can 
be identified from the intersection of low energy structures generated for each 
ortholog/homolog.6; 7  Briggs et al. demonstrated that this approach will identify 
the native conformation of glycophorin A.7 
The above methods use mutagenesis and phylogenetic information to 
identify correctly modeled conformations after an exhaustive computational 
search.  Our methods use mutagenesis or phylogenetic information to simplify 
the computational search.  Prior modeling efforts provide precedent for this 
approach.  Most membrane protein modeling protocols, including the protocols 
described above, simplify their computational search by only considering 
conformations with α-helical secondary structure.  Non-helical conformations can 
be excluded with structural restraints that maintain appropriate distances 
between the hydrogen bonding partners in an α-helix.  The structural restraints 
are enforced by a term in the energy function which is analogous to the energy 
function that enforces distances predicted by NMR spectroscopy.  Similar 
structural restraints can enforce tertiary or quaternary structure predicted by 
spectroscopy, crosslinking, mutagenesis, and/or sequence analysis.5; 8; 11; 12; 13; 14  
In contrast with structural restraints which enforce distances and angles, we use 
thermodynamic restraints which enforce relative differences in energy for an 
ensemble of mutations. 
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During each docking step of a Monte Carlo simulated annealing cycle, we 
compute the difference in dimerization energy ΔE between the wild type and an 
ensemble of point mutations for the step’s conformation.  The ΔE value should be 
near zero for mutations that do not affect protein stability and function.  Likewise, 
we expect an unfavorable ΔE for destabilizing mutations.  Conformations with 
computed ΔE values that are inconsistent with experimental findings are 
penalized by increasing their computed energies.  Thus our modeling protocol 
creates a selective advantage for models that are consistent with experimental 
mutagenesis results. 
We optimized our structure prediction protocol to study self associating 
transmembrane (TM) helices.  Self associating TM helices are widespread and 
play vital functional and structural roles such as in the T cell receptor,21 the M2 
proton channel,22 and phospholamban.23  For reviews see Engelman et al.24  and 
Senes et al.25  We calibrated our structure prediction protocol with glycophorin A 
(GPA), a small, well-characterized protein that dimerizes along two TM helices.  
We applied our structure prediction protocol to the TM region of BNIP3 because 
several labs were working to determine its NMR structure which could validate 
our modeling protocol.  Both GPA and BNIP3 contain GXXXG motifs.26; 27  The 
GXXXG motif is the most overrepresented sequence motif found in TM helices28 
and presents a strong dimerization signal.29  The motif consists of two glycines 
separated by three amino acids.  The glycines enable close contact which 
permits Cα-H•••O hydrogen bonding between helix backbones.30; 31  Cα-H•••O 
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hydrogen bonds, which are found in many proteins, may be important for 
stabilizing membrane proteins. 
Previously, our lab derived a conceptual basis for structure prediction 
guided by mutagenesis data using lattice models.32  Mutagenesis data can 
compensate for the limitations of a force field while permitting a significant 
increase in modeling speed.  Here we extend the approach to the docking of TM 
helices, and we use the method to predict a molecular model for the TM region of 
the BNIP3 apoptosis factor which was subsequently validated by an experimental 
NMR structure.33 
 
MATERIALS AND METHODS 
Potential Function 
We define dimerization energy Edimerization as the potential energy of two helices in 
a docked conformation minus the energy of the two helices separated by 100 Å.  
Potential energies were calculated in vacuo with the AMBER united-atom force 
field for van der Waals interactions.34  We softened the potential function to 
mitigate artifacts from rigid body docking.  Favorable van der Waals interactions 
were calculated with a 12-6 Lennard-Jones potential in which the van der Waals 
radii were scaled to 95%.  Unfavorable van der Waals interactions were 
dampened using a linear repulsive term with a 10 kcal per mole maximum 
repulsion.35 
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Calibration 
We calibrated our scoring function with glycophorin A’s (GPA) published structure 
and mutational data.26; 36  10,000 GPA helix-helix dimer pairs with computed 
dimerization energies less than –10 kcal per mole were generated during ten 
Monte Carlo simulated annealing (MCSA) cycles similar to the MCSA protocol 
described below.  A plot of these structures is shown in figure 1a.  Our scoring 
function was parameterized to selectively penalize low energy dimers with an 
RMSD greater than 1.5 Å with the GPA structure.  Specifically, we averaged the 
scores of the ten best scoring models with an RMSD less than 1.5 Å and the ten 
best scoring models with an RMSD greater than or equal to 1.5 Å and maximized 
the difference between these two averages.  Other more sophisticated 
optimization methods resulted in similar parameterization.  The scoring function 
is described in greater detail in the results section.  
 
MCSA Implementation 
The GPA TM helices consisted of residues Ile73 through Ile95 and the BNIP3 
helices consisted of residues Val164 through Gly184.  A single proline occurs at 
position 167 near the N-terminus of the BNIP3 helix and should not affect the 
backbone geometries of downstream residues.  It was modeled as alanine to 
eliminate its significance relative to the method we were testing.  φ, ϕ, and ω 
angles were fixed at –65°, –40°, and 180°, respectively, for all amino acids. 
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  Fig 1.  Each graph depicts the same set of conformations plotted with a different score 
on the y-axis.  The arrowheads track three conformations through the graphs and do not 
appear when a score is greater than 0 kcal.  Native-like conformations of glycophorin A 
(blue and green arrowheads) cannot be distinguished from other low energy 
conformations (red arrowhead) using computed van der Waals energies (a).  Penalties 
can be added to the van der Waals energies of models that are inconsistent with known 
disruptive mutations (b), neutral mutations (c), or both (d) to help distinguish native-like 
models from non-native conformations.  The penalties eliminate the non-native energy 
wells at the expense of removing some conformations from the native energy well. 
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Our MCSA protocol utilizes previously characterized point mutations for 
protein structure prediction.  The mutants used in this analysis are listed in table 
I.  GPA mutants were taken from Lemmon et al.26 and BNIP3 mutants were taken 
from Suljito et al.27  The GPA mutations were selected to preferentially probe the 
effect of alanine and leucine scanning mutagenesis on glycine and leucine amino 
acids because these mutations are commonly made and often insightful.  Less 
mutational data is available for BNIP3 and we used all point mutations that had 
unambiguous effects.  Additionally, naturally occurring sequence variation can 
serve as a source of mutational information.37  Single nucleotide polymorphisms 
(SNPs), orthologs, and homologs of GPA were identified with BLAST.38  Each 
mismatched amino acid was scored as a neutral mutation such that each 
sequence could contribute multiple neutral mutations to the analysis. 
A MCSA cycle began after finding a randomly generated conformation 
with a favorable dimerization energy (i.e. a dimerization energy less than zero).  
A conformation is defined by the six parameters that relate two rigid helices in 
space (figure 2).  During each docking step of a MCSA cycle, there was an equal 
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probability of changing any one parameter or all six parameters to random 
values.  In nine initial MCSA cycles, all possible values were allowed; the phase 
of each helix θ1 and θ2 varied 360°, the crossing angle χ varied from -90° to 90° 
(parallel structures only), translations along a helical axis z1 and z2 varied from –
15 to 15 Å, and the diameter d varied from 5 to 9 Å. 
 
 
 
  Fig 2 (next page).  The flowchart for a global Monte Carlo simulated annealing cycle.  
Idealized α-helices are docked with six orthogonal parameters: θ1 and θ2 are rotations of 
a helix about its helical axis, χ  is the crossing angle, z1 and z2 are translations of a helix 
along its helical axis, and d is the distance between each helical axis.  Global MCSA 
cycles explore all parameter space.  Subsequent MCSA cycles restrict parameter space to 
the energy well defined by nine global cycles and more thoroughly explore rotamer space 
(see text).  Each MCSA cycle consists of 50,000 docking steps which start at box 1 and 
end at box 15.  The simulated annealing temperature undergoes exponential decay from 
10,000 to 10 K over the 50,000 docking steps in each cycle. 
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After docking, rotamers were set to their most common helical rotamer.  
The helix-helix interface was defined by identifying residues with interaction 
energies greater than 10-3 kcal per mole in magnitude.  The rotamers of these 
residues were optimized by Monte Carlo or dead end elimination (DEE)39 using 
the Goldstein criterion40 depending on how many residues were at the helix-helix 
interface.  The rotamers of the monomeric states were optimized by DEE for 
every residue.  Rotamers were selected from a library containing the most 
common helical rotamers which consists of one to three members for each amino 
acid.41 
After rotamer optimization, the conformation’s dimerization energy was 
calculated.  If the dimerization energy was favorable, we calculated the 
dimerization energy of select point mutations.  The dimerization energies were 
used to calculate a score for the conformation (see equations 1-3 in the results 
section).  The score was used to accept or reject a conformation based on our 
simulated annealing criteria.  If a conformation was accepted, its six parameters 
were passed to the next docking step.  If a conformation was rejected, the 
parameters of the last accepted conformation were passed to the next step.  
Regardless of whether a conformation was accepted or rejected, its parameters 
and score were recorded to restrict conformational space in subsequent MCSA 
cycles (see below).  Each MCSA cycle consisted of 50,000 docking steps with an 
exponential temperature decay from 10,000 to 10 K. 
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MCSA, Restricted Parameter Space 
Nine global, independent MCSA cycles are sufficient to define an energy well that 
is consistent with an ensemble of mutations.  Afterward, parameters are 
restricted to ±2 standard deviations from their mean values for structures with a 
score within 10 kcal of the best structure.  This typically restricts parameter space 
by three orders of magnitude and allows for a fine-grained search through 
conformational space.  MCSA cycles were repeated as described above with 
additional optimization of χ angles: rotamers were optimized with DEE for every 
amino acid at the helix-helix interface and the rotamer’s χ angles were further 
optimized with a grid/Monte Carlo search.  Similarly, rotamers of the monomeric 
states were optimized by DEE and χ angles were further optimized with a 
grid/Monte Carlo search.  Our figures and analyses are based on the single best 
scoring models for GPA/BNIP3 that were identified during the fine-grained 
search.  These models are representative of the best scoring clusters. 
 
Implementation of Penalties used to Score Mutations 
The penalties used to score mutations (eq. 2 and 3 in the Results section) were 
implemented to handicap the energy of each conformation that was considered 
by the simulated annealing criterion.  The penalties serve to artificially increase 
the dimerization energy of conformations that are in poor thermodynamic 
agreement with experimentally characterized point mutations.  Thus a low energy 
structure that does not agree with experimental findings is less likely to pass the 
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simulated annealing criterion than a low energy structure that is in good 
agreement with experimental findings.  This provides a selective advantage for 
parameters that are in good agreement with experimental results, resulting in 
final models that agree well with experimental data. 
 
BNIP3 Hydrogen Bonding 
Mutational analysis of the BNIP3 TM region predicts an intermolecular hydrogen 
bond involving His173.27  Our model places His173 and Ser172 in proximity but 
not in contact.  The χ angles of His173 and Ser172 can be changed to 
isoenergetic states that support a hydrogen bond between the His173 Nδ or Nε 
and the Ser172 Oγ.  No other interhelical contact can support a hydrogen bond 
with His173 or Ser172. 
The C-terminus of BNIP3 was not modeled because it is not embedded in 
the membrane.  We extended the C-terminal helix of the final BNIP3 model and 
set each amino acid to its lowest energy rotamer.  This positions both Thr188 
residues in favorable van der Waals contact.  The geometry and distance 
between the Thr188 hydroxyls predicts a hydrogen bonding interaction prior to 
any optimization step. 
 
RESULTS 
An ideal structure prediction protocol would identify a native protein fold based 
solely on energy calculations.  A minimal Monte Carlo simulated annealing 
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protocol that computes only van der Waals energies cannot distinguish the native 
conformation of glycophorin A (GPA) from other low energy conformations (figure 
1a).  However the protocol is sufficient to identify low energy conformations that 
are consistent with the published NMR structure.  This result is similar to more 
sophisticated modeling protocols which cannot distinguish the native GPA fold 
from other low energy conformations without additional information.15; 18 
Mutagenesis data can help distinguish the native GPA structure from other 
low energy conformations.  For example, residues that are important for folding, 
as assessed from experimental mutagenesis studies, should lie at the helix-helix 
interface of a correct model and show strong interaction energies within the 
structure.  Treutlien et al. reported a GPA model which has residue interaction 
energies that best correlate with mutagenesis results.15; 18 
To automate the process of structure prediction using mutagenesis data, 
we compute the difference in dimerization energy ΔE between the wild type and 
select point mutants during each docking step.  The ΔE value can be compared 
to experimental results to allow for the penalization of models that are 
inconsistent with mutagenesis data.  In the current work we considered two 
phenotypes, disruptive and neutral mutations, which have been previously 
characterized experimentally.  By definition, disruptive mutations have 
unfavorable dimerization energies relative to the wild type while neutral mutations 
are isoenergetic with the wild type. 
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We built a scoring function to penalize conformations that are inconsistent 
with known disruptive and neutral mutations.  We calculate a score for each 
modeled conformation by summing its van der Waals energy and two penalties 
(equation 1). 
! 
scoreconformation = Edimerization + penaltydisruptive + penaltyneutral  1 
Edimerization is the energy of the dimer minus the energy of the monomeric state (see 
methods).  penaltydisruptive is a restraint that creates a selective advantage for 
conformations that are consistent with known disruptive mutations.  penaltyneutral is 
a restraint that creates a selective advantage for conformations that are 
consistent with known neutral mutations.  
Each disruptive mutant should have a higher computed dimerization 
energy than the wild type, otherwise we penalize a conformation’s score.  After 
examining a number of functions, we found equation 2 to be most effective at 
penalizing low energy conformations that are inconsistent with one or more 
disruptive mutations.  This function is plotted in figure 3a. 
! 
penaltydisruptive =
"disruptive
n
ln
1
1+ e
#$%Ei
& 
' 
( 
) 
* 
+ 
i=1
n
,  2 
ΔEi is the computed difference in energy between disruptive mutant i and the wild 
type protein for a given conformation.  n is the total number of disruptive mutants 
considered.  The α coefficient scales the magnitude of the penalty and the β 
coefficient shifts the curve from left to right.  The optimized values used for these 
coefficients are –60.1 and 0.521, respectively. 
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  Fig 3.  These functions penalize models that are inconsistent with a given mutation.  A 
disruptive mutation should have a positive ΔE (a) and a neutral mutation should have a 
near zero ΔE (b).  If a model is inconsistent with an experimental mutagenesis result, its 
computed energy is increased by adding a normalized penalty that corresponds to the 
computed ΔE for that mutant.  This creates a selective advantage for models that are 
consistent with mutational data. 
 
Each neutral mutant should have a computed dimerization energy that is 
comparable to the wild type.  When considering GPA, we found that the optimal 
scoring function penalizes models that have one or more neutral mutations with 
computed stabilizing or destabilizing effects (equation 3). 
! 
penaltyneutral =
"neutral
n
e
# $Ei
i=1
n
%  3 
Our optimized α and β values are 1.02E-2 and 9.63, respectively. 
We parameterized our scoring function to best penalize non-native low 
energy conformations (see methods).  When considering the mutations in table I, 
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the scoring function creates a new energy landscape for GPA and the new global 
energy minimum corresponds to the native conformation (figure 1d).  Each 
conformation is penalized by one or both penalties.  It is necessary to penalize 
some native-like conformations in order to effectively penalize all non-native 
conformations.  When the scoring function is applied to our MCSA protocol, some 
native-like conformations are eliminated from the analysis so that we can 
eliminate every low energy non-native conformation. 
We repeated the MCSA protocol for GPA with the two penalties added to 
the van der Waals energy function.  The best scoring model had a Cα root mean 
squared deviation (RMSD) with GPA of 1.30 Å (figure 4a).  This is an excellent 
result considering the lowest RMSD structure accessible to our search algorithm 
has an RMSD of 0.65 Å, and the TM regions of different NMR structures for GPA 
vary by up to 1.80 Å.  (There are twenty NMR structures for GPA in its pdb file 
1AFO; we used model 1 for calibration and RMSD calculations unless otherwise 
noted.)  Finally, our model recovers the Cα hydrogen bonding interactions 
described by Senes et al. even though no hydrogen bonding or electrostatic term 
was used to generate this model.31 
Briggs et al. demonstrated that phylogenetic analysis is sufficient to 
identify the native conformation of GPA.7  We repeated the MCSA protocol with 
the naturally occurring sequence variants from table II.  Encouragingly, the best 
scoring model had an RMSD with GPA of 1.37 Å (figure 4b).  This model also 
recovers the Cα hydrogen bonding interactions described by Senes et al.31 
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  Fig 4.  The glycophorin A model generated with thermodynamics data (red) fit to the 
wild type backbone (green), RMSD 1.30 Å (a).  The glycophorin A model generated with 
naturally occurring sequence variation data (blue) fit to the wild type backbone (green), 
RMSD 1.37 Å (b). 
 
  Fig 5.  The glycophorin A model generated with naturally occurring sequence variation 
data (blue) fit to structure 19 from the glycophorin A pdb (green), RMSD 0.54 Å.  The 
glycophorin A pdb file 1AFO contains twenty different NMR structures and structure 19 
shows the strongest Cα-H•••O hydrogen bonding interactions.  (Structure 1 was used for 
calibration and all other RMSD calculations.)  The two figures are related by a rotation 
about the vertical axis. 
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In fact, this structure has a Cα RMSD of 0.54 Å with the GPA NMR structure that 
shows the strongest Cα-H•••O hydrogen bonding interactions (figure 5). 
To further explore our method, we modeled the TM region of the BNIP3 
apoptosis factor which also contains a GXXXG motif.  The resultant model 
predicts a right-handed crossing angle of -42º and a similar conformation as 
GPA.  Our model accommodates an interhelix hydrogen bond between His173A 
and Ser172B.  The model is inconsistent with other interhelical hydrogen bonding 
partners for either His173 or Ser172.   Additionally, the model is consistent with 
an interhelix hydrogen bond between Thr188A and Thr188B (figure 6).  Finally, it 
predicts six interhelical Cα hydrogen bonds.  These include symmetrical 
hydrogen bonds between the Ile177A Cα and Ala176B carbonyl, the Gly180A Cα 
and Ile177B carbonyl, and the Ile181A Cα and Gly180B carbonyl. 
 
  Fig 6.  Molecular model of the BNIP3 homodimer. The TM helices dimerize along 
consecutive AXXXG and GXXXG motifs (red).  The TM regions of the protein are 
colored green and yellow, and aqueous regions are colored blue. 
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DISCUSSION AND CONCLUSIONS 
We developed a novel protein structure prediction strategy to model interactions 
between self-associating TM helices based on experimental mutagenesis results.  
The semi-quantitative determination of helix dimerization in response to 
mutagenesis was sufficient for this analysis.  In the case of GPA, naturally 
occurring sequence variation can substitute for mutational information to drive 
structure prediction.  However we suggest that experimental mutagenesis 
information be favored when available because sequence drift can be 
accompanied by structural drift. 
 
Scoring Function Analysis 
Our scoring functions provide a mathematical framework for the incorporation of 
experimental mutagenesis data into modeling protocols.  The scoring function is 
the linear combination of a van der Waals term, a penalty that evaluates 
disruptive mutations, and a penalty that evaluates neutral mutations.  The neutral 
penalty may be less intuitive than the disruptive penalty.  If a neutral mutant has 
a computed destabilizing effect, we penalize the model because we expect 
disruptive mutants to have computed destabilizing effects.  If a neutral mutant 
has a computed stabilizing effect, the interpretation is less straightforward 
because stabilizing mutations are often accompanied by structural changes.  For 
example, many mutations stabilize the overall tetramerization of the M2 proton 
channel, however they stabilize different accessible conformations of the 
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channel.42  If a single conformation is considered, stabilizing mutations are rare 
and small in magnitude.  Also, several mutations stabilize the integrin αIIb TM 
homodimer but each is predicted to stabilize a non-native conformation.43  
Therefore, if we calculate that a neutral mutation is stabilizing, the conformation 
may be accessible, however it is likely not native.  Thus strongly stabilizing 
mutations are penalized in our method, and they indeed help discriminate the 
native fold from alternately folded conformations. 
We calibrated our penalization functions with the well-characterized TM 
helix dimer from glycophorin A.  It is possible that the parameters we developed 
are most useful at predicting GPA-like structures.  However, our protocol 
identified a conformation that is different from the GPA conformation for two TM 
helices in tetraspanin CD9.44  Additionally, it identified both GPA-like and non-
GPA-like structures for the integrin αIIb/β3 TM heterodimer.45  Furthermore, it can 
distinguish between different subtypes of GXXXG motifs.43  Each of the above 
proteins contains one or more glycine-containing motifs which rely on geometric 
complementarity and potentially Cα-H•••O hydrogen bonds for stabilization, and 
our methods might prove especially useful at predicting these types of 
interactions.  Clearly, it would be desirable to include additional energetic terms 
to allow the scoring of hydrogen bonding interactions, electrostatics, rotamer 
strain, and other features that are important for association.  We chose, however, 
to use a simple energy function to analyze its performance in combination with 
mutagenesis data.  We demonstrated that a simple energy function is sufficient to 
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predict the association of TM helix dimers when used in combination with 
mutagenesis data.  A more sophisticated energy function may be necessary for 
the accurate prediction of more complex interactions. 
Qualitative thermodynamics information was sufficient to generate 
reasonable models for TM helix dimers, however quantitative information may 
increase structure prediction accuracy for larger proteins.  For example, each 
disruptive mutant could be weighted proportionally to its experimentally 
determined degree of destabilization.  A weighting coefficient could then be 
applied to the disruptive penalty to scale its magnitude for different mutations.  
However the penalties can be parameterized any number of ways to allow the 
addition of quantitative thermodynamics information. 
 
Molecular Model of BNIP3 
BNIP3 is a “BH3-only” member of the Bcl-2 family of apoptosis factors.  When 
localized to the mitochondrial membrane, BNIP3 inhibits anti-apoptotic proteins 
which otherwise block pore formation.46  Through this mechanism BNIP3 permits 
the release of mitochondrial contents causing cell death.  The function of BNIP3 
homodimerization remains unknown, however its tremendous stability suggests 
that its function requires a dimeric conformation.27 
 The BNIP3 TM dimer is more stable than the prototypical TM dimer 
glycophorin A.  Sulistijo et. al predicted that concurrent AXXXG and GXXXG 
motifs stabilize the BNIP3 homodimer in addition to electrostatic interactions 
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involving His173, and site directed mutagenesis corroborated their hypothesis.27  
Our model confirmed that the AXXXG and GXXXG motifs are at the homodimer 
interface and predicted an interchain hydrogen bond between His173 and 
Ser172.  Following the publication of our model, the BNIP3 NMR structure was 
released and the two conformations have a Cα RMSD of 1.06 Å, validating the 
model, and more importantly, the modeling method.33 
 
Conclusion 
We developed a novel molecular modeling protocol that selects modeled protein 
conformations based on experimental mutagenesis results.  In contrast to 
modeling protocols that enforce distance or angular restraints, we examine the 
relative stabilities for an ensemble of point mutations for each modeled 
conformation and create a selective advantage for conformations that are 
consistent with experimental findings.  This approach is sufficient to identify the 
native conformations of the glycophorin A and BNIP3 TM dimers without a 
sophisticated force field or an exhaustive search through conformational space.  
Importantly, the methodology was independently validated by the BNIP3 NMR 
structure. 
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CHAPTER 3 
 
Multiple Approaches Converge on the Structure of the 
Integrin αIIb/β3 Transmembrane Heterodimer 
 
INTRODUCTION 
Integrins, the principal cell surface receptors responsible for linking the 
cytoskeleton to the extracellular matrix, are transmembrane (TM) heterodimers 
composed of non-covalently associated α and β subunits. Integrin molecules 
exist in an equilibrium between resting conformations that do not bind 
extracellular ligands and active conformations that both engage ligands and 
nucleate large intracellular complexes.1; 2  Agonist-induced intracellular signals 
shift integrins from resting to active conformations by exposing extracellular 
ligand-binding sites.  To do so, signals must be transmitted across the membrane 
via the integrin’s TM domain: an integrin is constrained in a resting conformation 
by the heteromeric association of its α and β subunits’ TM domains.  Moreover, 
disruption of this association is sufficient to induce integrin activation (figure 7).3; 4  
Thus, the α/β TM heterodimer is a critical structure in regulating integrin function.   
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  Fig 7.  Integrins exist in equilibrium between resting and active conformations.  In the 
resting conformation, the integrin’s TM helices form an α/β heterodimer and the 
cytosolic  domains are held in proximity.  In the active conformation, the TM and 
cytosolic domains separate. 
 
One of the most widely studied examples of regulated integrin function is 
the platelet integrin αIIbβ3.  In its active conformation, αIIbβ3 binds fibrinogen, 
von Willebrand factor, or fibronectin and mediates platelet aggregation when 
these αIIbβ3-bound ligands crosslink adjacent platelets.5  To prevent the 
deleterious formation of intravascular platelet aggregates, αIIbβ3 is maintained in 
a resting conformation on circulating platelets.  Following vascular injury, αIIbβ3 
is rapidly activated, enabling it to mediate the formation of a hemostatic platelet 
plug.  The formation and disruption of the αIIb/β3 TM domain heterodimer are 
key events in shifting αIIbβ3 between resting and active conformations.  Thus, 
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there has been considerable effort to produce three-dimensional structural 
models of the TM domain heterodimer.6; 7; 8; 9; 10  However, each published model 
is substantially different and none have accounted well for the consequences of 
introducing mutations into the αIIb and β3 TM domains.  Because of the absence 
of a satisfactory model for the αIIb/β3 TM heterodimer, we explored two new and 
fundamentally different strategies to predict its structure. 
In the first strategy, we utilized the Monte Carlo algorithm described in 
Chapter 2.11  In the second strategy, we used a threading approach in which the 
sequences of the αIIb and β3 TM domains were threaded onto a set of TM 
dimers parsed from high resolution structures in the protein data bank.  Threaded 
structures were then scored according to their calculated energy and their 
agreement with experimental cysteine crosslinking results.  Although the Monte 
Carlo and threading strategies relied on different sets of empirical data, they 
converged on a similar structure that likely approximates the native conformation 
of the αIIb/β3 TM heterodimer. 
 
MATERIALS AND METHODS 
Mutations used in the Monte Carlo Modeling Algorithm 
We first modeled the αIIb/β3 TM domain heterodimer using the Monte Carlo-
based structure prediction strategy described in Chapter 2.11  The αIIb mutants 
Val969Asn, Leu970Asn, Leu974Asn, Gly975Asn, Leu983Ala and β3 mutants 
Ser699Asn, Val700Asn, Gly702Asn, Ile704Asn, Leu705Asn were scored as 
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neutral mutations, and the αIIb mutants Gly972Asn, Gly972Ala, Gly972Leu, 
Gly976Leu and β3 mutants Met701Asn and Gly708Asn were scored as 
disruptive mutations.2; 3  
 
αIIb I966WWVL VGVLG GLLLL TILVL AMW988 
β3 I693LV VLLSV MGAIL LIGLA ALLIW715  
  Fig 8.  Sequences of the αIIb and β3 TM domains.  Amino acids are highlighted if one 
or more of its mutants activate the integrin. 
 
Comparing the Monte Carlo Interface with Other Published Structures 
In order to sample every accessible dimer interface, our Monte Carlo method 
considers interfaces that are similar to those in published structures and 
theoretical interfaces that may not occur in nature.  To assess whether the Monte 
Carlo model might reflect a natural interface, Cα RMSDs were calculated 
between the model and conformations found in high resolution crystal structures 
from the orientations of proteins in membranes (OPM) database.12  Of the parallel 
helix dimers parsed from OPM structures, 28% (113 of 400) had Cα RMSDs less 
than 1.5 Å with the Monte Carlo model over at least ten residues from both the 
αIIb and β3 helices which demonstrates that the Monte Carlo interface frequently 
occurs in nature. 
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Threading Known Structures with the Integrin’s Sequence 
Threading is the modeling of an unknown structure based on the experimentally 
determined structures of other proteins.13; 14  While it is usually applied to 
problems in which the protein of unknown structure has a sequence that is highly 
similar to a protein of known structure, we thought it could be useful for the 
prediction of membrane helix pairs due to the limited number of packing motifs 
found between membrane helices.15  The αIIb amino acids Ile966-Trp988 and β3 
amino acids Ile693-Trp715 were threaded through 214 parallel TM helix dimers 
parsed from pdbs 1c3w, 1e12, 1ehk, 1eul, 1fx8, 1h2s, 1iwg, 1j4n, 1jb0, 1k4c, 
1kb9, 1kf6, 1kpl, 1kqf, 1l7v, 1l9h, 1m3x, 1m56, 1msl, 1nek, 1ocr, 1okc, 1pp9, 
1pv6, 1pw4, 1q16, 1q90, 1qla, 1rc2, 1rh5, 1u7g, 1xfh, and 1yew, and the Monte 
Carlo model was threaded as an internal control.  Sequences were threaded in 
all possible frames such that at least fifteen αIIb amino acids and fifteen β3 
amino acids overlapped at the same depth in the membrane.  If the integrin 
sequence was longer than the template helix, only the portion of sequence for 
which a three-dimensional template was available was evaluated.  When the 
template was longer than the integrin sequence, the additional amino acids were 
mutated to alanine to eliminate favorable contacts from the parent structure while 
maintaining a penalty for steric clashes.  This procedure generated >50,000 
models. 
 Each model was optimized prior to energy calculation: the side chain 
rotamers of each structure were selected with the SCWRL3 algorithm,16 then 
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each model was energy minimized in NAMD using the CHARMM force field.17; 18  
NAMD minimization consisted of 2000 conjugant-gradient steps with a R=10 
dielectric constant.  Dimerization energies were calculated using the potential 
function described in Chapter 2, where a dimerization energy is defined as the 
energy of the optimized model minus the energy of the model’s helices separated 
by 100 Å and re-optimized.  The 500 lowest energy models were filtered based 
on whether they were consistent with experimental cysteine crosslinking results. 
 Disulfide bonds crosslink αIIb-β3 amino acid pairs Gly972-Leu697, 
Gly972-Val700, Val969-Val696, Val971-Leu697, and Trp968-Val696 when the 
pair is mutated to cysteine.19  Accordingly, the distance between the Cβ atoms of 
each pair was calculated to determine whether a model was consistent with 
these results.  Gly972 was mutated to alanine to add its Cβ atom, and any Cβ-Cβ 
distance closer than 4 Å was set to 4 Å because this distance approaches the 
maximum yield for cysteine crosslinking.  Of the 500 low energy models, a “best” 
model was selected that has the shortest average distance for the five αIIb-β3 
residue pairs.  It consists of a template from the 1iwg pdb for the crystal structure 
of bacterial multidrug efflux transporter AcrB20 in which the αIIb TM amino acids 
Trp967-Trp988 were threaded onto 1iwg chain A residues 392-413, and the β3 
TM amino acids Ile693-Ala711 were threaded onto 1iwg chain A residues 466-
484.  The helices in this model were analyzed by HELANAL to characterize 
deviations from ideal structure and calculate interhelix crossing angles.21  Other 
cysteine mutant pairs have been analyzed in addition to the five robust 
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crosslinking pairs considered here, and these datapoints were saved for structure 
validation (below).19 
 
Correlation with Cysteine Crosslinking Experiments 
The Monte Carlo model, threaded model, and other published models were 
analyzed to determine whether they were consistent with the cysteine 
crosslinking experiments of Luo et al. that examined 120 αIIb-β3 cysteine mutant 
pairs to determine the extent to which they could crosslink the αIIb and β3 
subunits.19  Cysteine mutant pairs that are efficient at crosslinking the integrin 
should be close in space relative to pairs that are less efficient at crosslinking, 
and the distances between residues in a model should correlate with published 
cysteine crosslinking efficiency.  We correlated different models with cysteine 
crosslinking results as follows:  for each cysteine mutant pair, the disulfide bond 
formation efficiency was calculated by sampling its published color density in 
Adobe Photoshop CS.  Next, the distance between the Cβ atoms of each pair 
was calculated for a given model.  Glycine was mutated to alanine to add its Cβ 
atom.  A plot of the Cβ distance versus cysteine crosslinking efficiency was 
analyzed according to equation 4 using a non-linear least squares fitting routine 
implemented in KaleidaGraph.  This formula relates the percent yield (Yi,j) of the 
disulfide between the i and j residues in a given double mutant to the distance 
between their Cβ atoms di,j in a given model. 
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in which Ymax is the maximal yield observed for the protein of interest (generally 
slightly less than 1.0 due to competing side reactions), (di,j – 4.0) reflects the 
distance between the Cβ atoms with their van der Waals radii subtracted, and 
(d0.5 – 4.0) reflects the distance at which crosslinking is approximately 50%.  The 
value of n reflects the fact that the crosslinking generally has a high order 
dependence on the distance.  Finally a correlation coefficient was calculated for 
each fit to measure the accuracy of a given model. 
 
Correlation with Mutagenesis Experiments 
The Monte Carlo model, threaded model, and other published models were 
analyzed to determine whether they are consistent with published mutagenesis 
results.  TM mutations that activate the integrin cause the αIIb/β3 TM 
heterodimer to separate, and these positions are likely to reside at the 
heterodimer interface.2; 3; 10; 22  To determine whether a residue is at a model’s 
interface, we calculated its fractional change in solvent accessibility in the model 
and in the model’s separated helices.  First, the solvent accessibility of each 
amino acid was calculated using DSSP.23  Then the solvent accessibility was 
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recalculated for the separated helices.  The fractional change in solvent 
accessibility, fasa,i was calculated with equation 5 
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in which modelASA,i is the solvent accessible surface area of the ith residue in a 
model, and monomerASA,i is the solvent accessibility of the same residue when the  
model’s helices are isolated.24  The fASA measurement was then correlated with 
experimental mutagenesis results using linear regression.  For this analysis, a 
residue was assigned a value of 1 if at least one of its mutants activates the 
integrin.  These positions should reside at the heterodimer interface and have 
fractional changes in solvent accessibility that approach 1.  Other positions that 
have been probed by mutagenesis were valued 0.  These positions should 
cluster away from the heterodimer interface and have fractional changes in 
solvent accessibility that approach zero.  Mutations to hydrophilic amino acids 
were disregarded because they can affect oligomerization and orientation in a 
membrane, and mutations to threonine were disregarded because threonine can 
perturb the secondary structure of a helix.25; 26  In summary, a model’s calculated 
fASA values were correlated with a binary index of positions that can activate the 
integrin when mutated. 
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Assessment of the Putative Arg995-Asp723 Salt Bridge 
Reciprocal mutagenesis suggests that an interaction between αIIb Arg995 and 
β3 Asp723 stabilizes the integrin’s resting state.27  The αIIb and β3 helices in the 
Monte Carlo and threaded models were extended to Arg995 and Asp723 using 
ideal backbone geometries (φ = -65º; ϕ = -40º; ω = 180º) and the feasibility of a 
salt bridge was assessed by the manual manipulation of the Arg995 and Asp723 
χ angles.  Arg995 and Asp723 were proximal in both the Monte Carlo and 
threaded models, but only the threaded model allowed for the formation of a 
Arg995-Asp723 salt bridge. 
 
RESULTS 
Monte Carlo α IIb/β3 Model  
In the Monte Carlo-based algorithm, two straight helices consisting of αIIb amino 
acids Ile966-Trp988 and β3 amino acids Ile693-Trp715 were docked by randomly 
altering the six orthogonal parameters that orient two cylinders in space.11  The 
algorithm’s scoring function was designed to favor conformations that were 
consistent with published mutagenesis experiments by including a selective 
advantage for disruptive mutations having higher energies than the wild type and 
for neutral mutations that are iso-energetic.  Inclusion of mutagenesis information 
compensates for approximations made during energy calculations and the limited 
conformational space accessible to the search algorithm.28  This strategy enabled 
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us to accurately predict the structures of the TM homodimers for glycophorin A 
and BNIP3 (see Chapter 2).11; 29 
When applied to αIIb and β3, the Monte Carlo-based algorithm converged 
on a structure with an angle of 18º between the two helical axes and a right-
handed orientation (figure 9).  This type of interaction occurs frequently in 
membrane proteins,15 and its conformation is similar to >100 different TM dimer 
interfaces reported in the protein data bank (see Methods).  The heterodimer 
interface for αIIb consisted of residues Trp968, Val969, Gly972, Gly976, Leu980, 
Leu983, and Met987 and the β3 interface consisted of Ile693, Val696, Leu697, 
Val700, Met701, Ile704, Gly708, Leu712, and Trp715.  This structure is 
consistent with a published cysteine crosslinking analysis that examined 120 
possible pairwise interactions in the αIIbβ3 TM region, even though cysteine 
crosslinking data was not considered in the modeling procedure (figures 10 and 
12).19  The structure is also consistent with mutational analyses of the αIIb and β3 
TM domains with the exception of mutations involving αIIb residue Thr981 that 
activate αIIbβ3 expressed in tissue culture cells, but reside on the opposite side 
of the αIIb helix from other activating mutations.2; 3; 10; 22 
 In addition to a TM heterodimer, αIIbβ3 function is thought to be 
constrained by a “clasp” involving membrane-proximal portions of the αIIb and β3 
cytoplasmic domains, a notable feature of which is a salt-bridge between Arg995 
in αIIb and Asp723 in β3.27  Several previous NMR models of the αIIb and β3 
cytoplasmic domains predict that Arg995 and Asp723 reside in helices, implying 
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that the αIIb and β3 TM helices might extend into the cytosol, at least through 
Arg995 and Asp723.30; 31; 32; 33; 34  When our Monte Carlo-derived model is 
propagated into the cytosol with straight helices, the distance between the 
Arg995 and Asp723 Cβ atoms is 12 Å, too far to form a salt bridge, however 
perturbations from uniform helical structure might allow for an Arg995-Asp723 
interaction. 
 
  Fig 9.  The Monte Carlo model of the αIIb/β3 TM heterodimer.  On the left, the αIIb 
helix is depicted as a surface representation (red) and the β3 helix is shown as a stick 
representation (cyan).  Mutagenesis indicates that Gly972, Gly976, and Leu980 (blue) 
reside at the heterodimer interface.  On the right, the β3 helix is depicted as a surface 
representation (blue).  Mutagenesis indicates that Gly708 (red) is at the heterodimer 
interface.   
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  Fig 10.  Slices through the Monte Carlo model with amino acids highlighted (yellow) 
that have a strong propensity to form a disulfide bond when the pair is mutated to 
cysteine.  Leu697 lies between its crosslinking partners Val971 and Gly972.  Gly972 lies 
between its crosslinking partners Leu697 and Val700.  Finally, Val696 lies between its 
crosslinking partners Trp968 and Val969. 
 
Threaded α IIb/β3 Model  
To verify the Monte Carlo structure, we used threading as a different approach to 
derive a model for the αIIb/β3 TM heterodimer.  In contrast with the Monte Carlo-
based methods, threading makes use of experimentally determined structures, 
sampling real protein conformations rather than theoretical geometries.  Thus, 
threaded models can account for kinks, bends, coiling, and other deviations from 
ideal helical structure with physically accessible conformations.  
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We threaded the αIIb and β3 TM sequences through 214 parallel TM helix 
dimers found in high-resolution crystal structures.  The sequences were threaded 
in multiple different frames to generate >50,000 structures.  Each conformation 
was optimized by SCWRL3.016 followed by 2000 conjugant-gradient steps in 
NAMD,17 and their dimerization energies were calculated.  The top 1% lowest 
energy structures were analyzed to determine whether they were consistent with 
cysteine crosslinking results, which complements the use of mutagenesis results 
in the Monte Carlo strategy.  Specifically, the distance was measured between 
the Cβ atoms of five αIIb-β3 residue pairs having a high propensity to form a 
disulfide bond when the pair is mutated to cysteine.19  (The remaining 115 
experimentally evaluated cysteine mutant pairs were saved for structure 
validation, see below).  The structure with the most consistent average Cβ 
distance came from the 1iwg pdb of the crystal structure for the bacterial 
multidrug efflux transporter AcrB20 consisting of αIIb Trp967-Trp988 threaded on 
chain A residues 392-414 and β3 Ile693-Ala711 threaded on chain A residues 
466-484.  
As was the case for the Monte Carlo model, the threaded model has a 
right-handed crossing.  However, due to the non-linearity of natural helical axes, 
the interhelix crossing angles in the threaded model range from 48º in the heart 
of the GXXXG interface to 3.5º near its C-terminus.  The steepest crossing angle 
(48º) occurs between αIIb residues Gly972-Gly975 and β3 residues Ser699-
Gly702, and this conformation is characteristic of a canonical GXXXG interaction, 
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which is a dimerization motif found in TM helices.15; 35; 36; 37  While the β3 helix is 
relatively straight, the αIIb helix is kinked by 35º between residues Gly975 and 
Gly976 which extends the αIIb-β3 interface beyond the GXXXG motif and permits 
interactions near the membrane-cytosol boundary.  Additionally, when the TM 
helices were propagated into the cytosol, the structure allowed for an interaction 
characteristic of the putative Arg995-Asp723 salt bridge.  The αIIb interface 
consisted of residues Trp968, Val969, Gly972, Gly976, Leu980, Leu983, and 
Met987 and the β3 interface consisted of Ile693, Val696, Leu697, Val700, 
Met701, Ile704, and Gly708, essentially identical to the Monte Carlo model and 
consistent with both mutational analyses and the additional cysteine crosslinking 
pairs that were not used to score the model (figures 11 and 12).  Finally, the Cα 
RMSD between the Monte Carlo and threaded models is 1.3 Å indicating similar 
structure. 
 
Correlation with Experimental Results 
The Monte Carlo and threaded models and other published models were 
correlated with experimental mutagenesis and cysteine crosslinking results.  Four 
three-dimensional models have been previously reported for the αIIb/β3 TM 
heterodimer at atomic level resolution.  Two of the models were generated by 
Monte Carlo methods that did not take into account experimental data (literature 
models A and B).10  The other two models were generated from molecular 
dynamics simulations of integrin homologs that converged on two conformations,  
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TABLE III.  Comparison of α IIb/β3 TM models 
 agreement with empirical data 
model M T A B 1 2 
disulfides +++ +++ - + ++ +++ 
mutagenesis ++ +++ ++ - + ++ 
salt bridge - + - - - + 
 
  Model similarity, Cα RMSD in Å  
model M T A B 1 2 
Monte Carlo  1.3 * * 2.4 1.1 
Threading 1.3  * * 2.4 1.6 
Model A * *  * * * 
Model B * * *  * * 
Model 1 2.4 2.4 * *  2.3 
Model 2 1.1 1.6 * * 2.3  
reference   10 10 9 9 
 * denotes a Cα RMSD greater than 3 Å 
  TABLE III.. A qualitative analysis of the Monte Carlo model, the threaded model, and 
four published models.  The Monte Carlo and threaded models are most consistent with 
experimental results.  “Disulfides” indicates whether a model is consistent with published 
cysteine crosslinking results, “mutagenesis” indicates whether a model is consistent with 
published mutational analyses, and “salt bridge” indicates whether a model is consistent 
with the putative Arg995-Asp723 interaction.  Quantitative analyses are shown in figures 
11 and 12.  Additionally, the structural similarity of each model is reported as Cα atom 
root mean squared deviations in angstroms (RMSD).  A RMSD of 0 would indicate that 
two models are identical and a RMSD less than 2 indicates that two models are similar.  
The Monte Carlo model, threaded model, and literature model 2 are structurally similar. 
 
with representative structures reported for αIIbβ3 (literature models 1 and 2).9  
Additional models of the αIIb/β3 TM heterodimer have been reported but were  
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not considered here because they did not include atomic coordinates38 or contain 
a number of D-amino acids.6; 7; 8 
 First, we considered how well each model correlates with the 
consequences of mutating either the αIIb or the β3 TM domain, focusing on 
mutations that induce constitutive αIIbβ3 activation and thus are likely present in 
the heterodimer interface.  The fractional change in solvent accessibility was 
correlated with experimental mutagenesis results as shown in figure 11.  For this 
analysis, residues were assigned a value of 1 if at least one of its mutants 
activates the integrin (large green bar; missing bars indicate points for which data 
is not available).  These positions should reside at the heterodimer interface and 
have fractional changes in solvent accessibility that approach 1 (peaks in red for 
αIIb, blue for β3).  Mutations with no significant effect on activation were valued 0 
(small green bar).  These positions should cluster away from the heterodimer 
interface and have fractional changes in solvent accessibility that approach zero 
(red/blue minima).  Disruptive mutations that occur at a model’s heterodimer 
interface are marked with a “+” and indicate positive correlation.  We also 
computed a correlation coefficient, R, for each model (figure 11), although we 
note that a perfectly correlating model would not have an R=1 because the 
mutagenesis results were treated in a binary manner.  An example of a poorly 
correlating structure is literature model B, which displays poor overall correlation 
between fasa,i and experimental mutagenesis results (R = 0.06).  The Monte Carlo 
and threaded models have the best correlation coefficients (R = 0.46 and 0.57). 
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  Fig 11. Point mutations can activate the integrin (large green bars) or have no effect 
(small green bars; missing bars indicate positions for which mutagenesis information is 
not available).  Activating mutations are likely to reside at the αIIb/β3 heterodimer 
interface.  The interface of each model was defined using a calculation based on each 
amino acid’s solvent accessible surface (red and blue lines, see equation 5).  A model is 
consistent with experimental mutagenesis results if each activating mutation (large green 
bar) occurs at the model’s interface (large change in solvent accessible surface).  
Experimental mutagenesis results were correlated with the fractional change in solvent 
accessible surface using linear regression, and each correlation coefficient R is reported. 
 
Overall, the Monte Carlo and threaded models correlated with experimental 
mutagenesis results while other models correlated to a lesser extent, or not at all.
 Next, the models were correlated with the results of introducing disulfide 
crosslinks between the αIIb and β3 TM domains.  Luo et al. expressed full length 
αIIbβ3 in 293T cells with single cysteine replacements in both the αIIb and β3 TM 
helices and measured the efficiency of disulfide bond formation, based on the 
premise that positions forming disulfide crosslinks should be closer in space than 
positions that do not crosslink the integrin.19  Thus, the distance between the Cβ 
atoms of two cysteine residues in a model were correlated with the 
experimentally determined crosslinking efficiency for the pair (figure 12). For a 
quantitative comparison, it would be ideal to obtain the rates of the crosslinking 
reaction under carefully controlled conditions.  Also, in comparing the 
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  Fig 12.  When single cysteine point mutations are introduced into both the αIIb and β3 
TM helices, a disulfide bond can crosslink the integrin subunits.  Cysteine crosslinking 
yield correlates with the distance between two cysteines, and these distances can be 
measured in a given model.  Cβ distances for cysteine mutant pairs was plotted against 
the experimentally observed cysteine crosslinking yield and fit to equation 4.  The 
correlation coefficient of each fit is reported as R. 
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experimental data to computational models, it would be ideal to consider not only 
interatomic distances, but also the angular relationship between Cα–Cβ bond 
vectors and the local dynamics of the structure.39  However, even in the absence 
of this information, a modest correlation can be observed between the extent of 
disulfide formation and the distance between the interacting residues.40 
The Cβ distances in the Monte Carlo model correlate well with the 
cysteine crosslinking data (R = 0.82); furthermore, the equation 4 parameters of 
d0.5 = 7.8 Å and n = 4 are consistent with values reported in the literature.39  A 
similar good correlation was observed for the threaded model (R = 0.77; d0.5 = 7.7 
Å; n = 3.1), and for literature model 2 (R = 0.73; d0.5 = 8.5 Å; n = 3.4).  A less 
good correlation was observed for literature model 1 (R = 0.56; d0.5 = 6.9 Å; n = 
1.6), and a poor correlation was observed for literature models A and B. 
 
DISCUSSION AND CONCLUSIONS 
Although it has not yet been possible to determine the complete integrin structure 
at high resolution, partial structural information has been derived from 
mutagenesis,2; 3; 10; 22; 27 crosslinking,19; 41; 42; 43; 44 FRET experiments,4; 45 electron 
microscopy,44; 46; 47; 48 crystallographic and NMR analyses of integrin fragments,30; 
31; 32; 33; 34; 49; 50; 51; 52; 53; 54 and molecular modeling.6; 7; 8; 9; 10  Notably, the extracellular 
portions of the integrins αvβ3 and αIIbβ3 have been crystallized in conformations 
that are believed to represent their resting and active states.49; 50; 52  Additionally, 
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NMR has been used to obtain structures of peptides corresponding to the 
individual αIIb and β3 TM domains,53; 54 individual cytosolic  domains,30; 34 and 
complexes between the αIIb and β3 cytosolic  domains.31; 33; 55  However the 
experimental determination of structures for a TM heterodimer has proven to be 
challenging.  Here, we describe two fundamentally different modeling approaches 
that converged on the same structure for the αIIb/β3 TM heterodimer.  This 
conformation differs from previously published models and favorably compares 
with experimental data. 
 
Review of Published Integrin TM Heterodimer Models 
Gottschalk et al. performed the first structural analysis of the integrin TM 
heterodimer using a grid/molecular dynamics protocol pioneered by Axel 
Brunger.7; 56; 57  αIIbβ3 was modeled in parallel with homologous integrins in order 
to identify an evolutionarily conserved structure.  Twelve different conformations 
were identified and a right-handed structure with a small crossing angle was 
judged to be in best qualitative agreement with the then-available experimental 
data.  Subsequently, Gottschalk and Kessler modeled a portion of the αIIb/β3 TM 
heterodimer via a molecular dynamics simulation that utilized interchain distance 
restraints derived from NMR and an additional restraint imposed for the putative 
Arg995-Asp723 salt bridge.8  These simulations converged on a single structure 
that is consistent with a right-handed coiled coil.  Recently, Gottschalk modeled 
the αIIb/β3 TM heterodimer with a simulated annealing protocol that utilized 
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distance restraints extrapolated from a cysteine crosslinking analysis and an 
additional restraint for the Arg995-Asp723 salt bridge.6  This method converged 
on a single conformation consistent with a right-handed coiled coil.  However, 
Gottschalk’s models contain a number of D-amino acids, possibly because of 
unfavorable contacts in the starting coordinates, so the resultant models contain 
a number of inverted stereo-centers. 
On the basis of reconstructed electron cryomicroscopy images for low 
affinity αIIbβ3, Adair and Yeager proposed that the TM domains of resting αIIbβ3 
form a coiled coil and modeled it as either a left-handed or a right-handed 
heterodimer by placing the Arg995-Asp723 salt bridge at the interface.38  They 
noted that the right-handed coiled coil positioned more conserved amino acids at 
the heterodimer interface; however these models were not considered in this 
analysis. 
Substantially different structures were proposed by Partridge et al.10  Four 
hundred conformations were generated by Monte Carlo and representative 
structures were selected from two heavily populated clusters that passed 
geometric filters (literature models A and B).  One of the conformations predicted 
the effect of subsequent point mutations (model A).   
Finally, Lin and coworkers performed a grid search of conformational 
space followed by molecular dynamics for each grid point using the sequences of 
each human integrin homolog in order to identify an evolutionarily conserved 
structure.9  This method is similar to the original work of Gottschalk et al, however 
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proper chirality was maintained.  Two conformations were identified (literature 
models 1 and 2) and model 2 was predicted to reflect the resting αIIb/β3 TM 
heterodimer.   
Previously, we published a model of the integrin TM heterodimer using a 
Monte Carlo strategy that included a selective advantage for conformations that 
were consistent with experimental mutagenesis results, using an earlier 
generation of the Monte Carlo software described in Chapter 2.2  In our original 
publication, we were able to identify the same interface reported here, but were 
unable to distinguish models with “shallow” interhelix crossing angles (-18º) from 
those with “glycophorin-like” crossing angles (-40º).  We have since re-
parameterized the scoring function11 and the revised protocol consistently 
identifies structures with a crossing angle around -18º.  Finally, this chapter 
describes an additional threading method used to generate a model that is 
consistent with experimental cysteine crosslinking results.  The resulting model is 
essentially identical to the Monte Carlo model, except it introduces a slight kink in 
the αIIb subunit which allows for a larger crossing angle near the GXXXG 
interface, similar to a canonical, glycophorin-like interaction. 
 
Analysis of Different Models  
An accurate model successfully predicts experimental results, and each 
published model of the αIlb/β3 TM heterodimer is buttressed by one or more 
empirical findings; however, each model has substantially different structure. 
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  Fig 13.  (a) The αIIb helices of each model were aligned and a single αIIb helix is 
displayed as a gray ribbon.  Models have similar αIIb interfaces if their β3 helices  
overlap (cylinders).  (b) The β3 helices of each model were aligned and a single β3 helix 
is displayed as a gray ribbon.  Models have similar β3 interfaces if their αIIb helices 
overlap (cylinders).  (c) Alignment of the Monte Carlo model, the threaded model, and a 
previously published model (literature model 2).  These models have similar structure. 
 Residues Gly972, Gly976, Leu980, and Gly708 are highlighted in red.  
Mutagenesis indicates that these residues are at the αIIb/β3 heterodimer interface.  The 
models are color coded as follows: Monte Carlo model, red; threaded model, orange; 
model A, purple; model B, blue; model 1, green; model 2, yellow. 
 
To quantitatively assess the accuracy with which a model predicts experimental 
results, we performed objective measurements on each model and correlated 
these measurements with published experimental findings.  First, fractional 
changes in solvent accessibility were correlated with published experimental 
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mutagenesis results; the Monte Carlo and threaded models reported here had 
the highest correlation coefficients.  Additionally, the distance between different 
αIIb and β3 residues was correlated with published cysteine crosslinking results; 
again the Monte Carlo and threaded models had the highest correlation 
coefficients.  Of the other models, literature model 2 had the strongest correlation 
with experimental results and this model was structurally similar to the Monte 
Carlo and threaded models with Cα RMSDs of 1.1 and 1.6 Å, respectively.  It is 
noteworthy that model 2 was generated by a molecular dynamics method 
fundamentally different from the Monte Carlo and threading methods, and 
selected models based on integrin homology rather than functional or 
crosslinking data.9   
 
Comparison with Models in Press 
There are currently two additional models of the αIIb/β3 TM heterodimer in press 
including a NMR structure55 and a model generated by the Rosetta algorithm 
using restraints derived from experimental cysteine crosslinking results.  Of the 
models considered here, the Monte Carlo and threaded models are most 
consistent with the NMR structure with RMSDs of 1.2 and 1.3 Å, respectively.  
The Rosetta model has divergent structure that is more similar to the NMR 
structure of glycophorin A than the models reported here. 
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Table IV.  Structural comparison of top performing models and models in press 
 Monte Carlo Threading Model 2 NMR Rosetta 
Monte Carlo  1.3 1.1 1.2 1.9 
Threading 1.3  1.6 1.3 1.4 
Model 2 1.1 1.6  1.5 2.3 
NMR 1.2 1.3 1.5  1.7 
Rosetta 1.9 1.4 2.3 1.7  
Reference   9 55 58 
values correspond to Cα RMSDs in Å  
 
Conclusion 
We generated two models of the αIIb/β3 TM domain heterodimer using 
fundamentally different methods:  a Monte Carlo algorithm that selected 
conformations based on their agreement with published mutagenesis results and 
a threading method that selected conformations based on their agreement with 
cysteine crosslinking results.  The two methods converged on a similar structure, 
and when compared to previously published models, the Monte Carlo and 
threaded models were most consistent with reported experimental findings, 
suggesting they are most likely to reflect the native structure of the αIIb/β3 TM 
heterodimer.  These models have now been confirmed by its recently published 
NMR structure. 
 
References                                                                      . 
1. Hynes, R. O. (2002). Integrins: bidirectional, allosteric signaling machines. 
Cell 110, 673-87. 
 64 
2. Li, W., Metcalf, D. G., Gorelik, R., Li, R., Mitra, N., Nanda, V., Law, P. B., 
Lear, J. D., Degrado, W. F. & Bennett, J. S. (2005). A push-pull 
mechanism for regulating integrin function. Proc Natl Acad Sci U S A 102, 
1424-9. 
3. Li, R., Mitra, N., Gratkowski, H., Vilaire, G., Litvinov, R., Nagasami, C., 
Weisel, J. W., Lear, J. D., DeGrado, W. F. & Bennett, J. S. (2003). 
Activation of integrin alphaIIbbeta3 by modulation of transmembrane helix 
associations. Science 300, 795-8. 
4. Kim, M., Carman, C. V. & Springer, T. A. (2003). Bidirectional 
transmembrane signaling by cytoplasmic domain separation in integrins. 
Science 301, 1720-5. 
5. Bennett, J. S. (2005). Structure and function of the platelet integrin 
alphaIIbbeta3. J Clin Invest 115, 3363-9. 
6. Gottschalk, K. E. (2005). A coiled-coil structure of the alphaIIbbeta3 
integrin transmembrane and cytoplasmic domains in its resting state. 
Structure 13, 703-12. 
7. Gottschalk, K. E., Adams, P. D., Brunger, A. T. & Kessler, H. (2002). 
Transmembrane signal transduction of the alpha(IIb)beta(3) integrin. 
Protein Sci 11, 1800-12. 
8. Gottschalk, K. E. & Kessler, H. (2004). Evidence for hetero-association of 
transmembrane helices of integrins. FEBS Lett 557, 253-8. 
 65 
9. Lin, X., Tan, S. M., Law, S. K. & Torres, J. (2006). Unambiguous 
prediction of human integrin transmembrane heterodimer interactions 
using only homologous sequences. Proteins 65, 274-9. 
10. Partridge, A. W., Liu, S., Kim, S., Bowie, J. U. & Ginsberg, M. H. (2005). 
Transmembrane domain helix packing stabilizes integrin alphaIIbbeta3 in 
the low affinity state. J Biol Chem 280, 7294-300. 
11. Metcalf, D. G., Law, P. B. & DeGrado, W. F. (2007). Mutagenesis data in 
the automated prediction of transmembrane helix dimers. Proteins 67, 
375-84. 
12. Lomize, M. A., Lomize, A. L., Pogozheva, I. D. & Mosberg, H. I. (2006). 
OPM: orientations of proteins in membranes database. Bioinformatics 22, 
623-5. 
13. Bowie, J. U., Luthy, R. & Eisenberg, D. (1991). A method to identify 
protein sequences that fold into a known three-dimensional structure. 
Science 253, 164-70. 
14. Jones, D. T., Taylor, W. R. & Thornton, J. M. (1992). A new approach to 
protein fold recognition. Nature 358, 86-9. 
15. Walters, R. F. & DeGrado, W. F. (2006). Helix-packing motifs in 
membrane proteins. Proc Natl Acad Sci U S A 103, 13658-63. 
16. Canutescu, A. A., Shelenkov, A. A. & Dunbrack, R. L., Jr. (2003). A graph-
theory algorithm for rapid protein side-chain prediction. Protein Sci 12, 
2001-14. 
 66 
17. Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., 
Chipot, C., Skeel, R. D., Kale, L. & Schulten, K. (2005). Scalable molecular 
dynamics with NAMD. J Comput Chem 26, 1781-802. 
18. Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., 
Swaminathan, S. & Karplus, M. (1983). CHARMM: A program for 
macromolecular energy  minimization and dynamics calculations. J. 
Comp. Chem. 4, 187-217. 
19. Luo, B. H., Springer, T. A. & Takagi, J. (2004). A specific interface 
between integrin transmembrane helices and affinity for ligand. PLoS Biol 
2, e153. 
20. Murakami, S., Nakashima, R., Yamashita, E. & Yamaguchi, A. (2002). 
Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 419, 
587-93. 
21. Bansal, M., Kumar, S. & Velavan, R. (2000). HELANAL: a program to 
characterize helix geometry in proteins. J Biomol Struct Dyn 17, 811-9. 
22. Luo, B. H., Carman, C. V., Takagi, J. & Springer, T. A. (2005). Disrupting 
integrin transmembrane domain heterodimerization increases ligand 
binding affinity, not valency or clustering. Proc Natl Acad Sci U S A 102, 
3679-84. 
23. Kabsch, W. & Sander, C. (1983). Dictionary of protein secondary 
structure: pattern recognition of hydrogen-bonded and geometrical 
features. Biopolymers 22, 2577-637. 
 67 
24. Lee, B. & Richards, F. M. (1971). The interpretation of protein structures: 
estimation of static accessibility. J Mol Biol 55, 379-400. 
25. Deupi, X., Olivella, M., Govaerts, C., Ballesteros, J. A., Campillo, M. & 
Pardo, L. (2004). Ser and Thr residues modulate the conformation of pro-
kinked transmembrane alpha-helices. Biophys J 86, 105-15. 
26. Moore, D. T., Berger, B. W. & DeGrado, W. F. (2008). Protein-protein 
interactions in the membrane: sequence, structural, and biological motifs. 
Structure 16, 991-1001. 
27. Hughes, P. E., Diaz-Gonzalez, F., Leong, L., Wu, C., McDonald, J. A., 
Shattil, S. J. & Ginsberg, M. H. (1996). Breaking the integrin hinge. A 
defined structural constraint regulates integrin signaling. J Biol Chem 271, 
6571-4. 
28. Nanda, V. & DeGrado, W. F. (2005). Automated use of mutagenesis data 
in structure prediction. Proteins 59, 454-66. 
29. Bocharov, E. V., Pustovalova, Y. E., Pavlov, K. V., Volynsky, P. E., 
Goncharuk, M. V., Ermolyuk, Y. S., Karpunin, D. V., Schulga, A. A., 
Kirpichnikov, M. P., Efremov, R. G., Maslennikov, I. V. & Arseniev, A. S. 
(2007). Unique dimeric structure of BNip3 transmembrane domain 
suggests membrane permeabilization as a cell death trigger. J Biol Chem 
282, 16256-66. 
 68 
30. Vinogradova, O., Vaynberg, J., Kong, X., Haas, T. A., Plow, E. F. & Qin, J. 
(2004). Membrane-mediated structural transitions at the cytoplasmic face 
during integrin activation. Proc Natl Acad Sci U S A 101, 4094-9. 
31. Vinogradova, O., Velyvis, A., Velyviene, A., Hu, B., Haas, T., Plow, E. & 
Qin, J. (2002). A structural mechanism of integrin alpha(IIb)beta(3) "inside-
out" activation as regulated by its cytoplasmic face. Cell 110, 587-97. 
32. Li, R., Babu, C. R., Valentine, K., Lear, J. D., Wand, A. J., Bennett, J. S. & 
DeGrado, W. F. (2002). Characterization of the monomeric form of the 
transmembrane and cytoplasmic domains of the integrin beta 3 subunit by 
NMR spectroscopy. Biochemistry 41, 15618-24. 
33. Weljie, A. M., Hwang, P. M. & Vogel, H. J. (2002). Solution structures of 
the cytoplasmic tail complex from platelet integrin alpha IIb- and beta 3-
subunits. Proc Natl Acad Sci U S A 99, 5878-83. 
34. Vinogradova, O., Haas, T., Plow, E. F. & Qin, J. (2000). A structural basis 
for integrin activation by the cytoplasmic tail of the alpha IIb-subunit. Proc 
Natl Acad Sci U S A 97, 1450-5. 
35. MacKenzie, K. R., Prestegard, J. H. & Engelman, D. M. (1997). A 
transmembrane helix dimer: structure and implications. Science 276, 131-
3. 
36. Senes, A., Gerstein, M. & Engelman, D. M. (2000). Statistical analysis of 
amino acid patterns in transmembrane helices: the GxxxG motif occurs 
 69 
frequently and in association with beta-branched residues at neighboring 
positions. J Mol Biol 296, 921-36. 
37. Lemmon, M. A., Treutlein, H. R., Adams, P. D., Brunger, A. T. & 
Engelman, D. M. (1994). A dimerization motif for transmembrane alpha 
helices. Nature, Structural biology 1, 157-163. 
38. Adair, B. D. & Yeager, M. (2002). Three-dimensional model of the human 
platelet integrin alpha IIbbeta 3 based on electron cryomicroscopy and x-
ray crystallography. Proc Natl Acad Sci U S A 99, 14059-64. 
39. Careaga, C. L. & Falke, J. J. (1992). Structure and dynamics of 
Escherichia coli chemosensory receptors. Engineered sulfhydryl studies. 
Biophys J 62, 209-16; discussion 217-9. 
40. Bass, R. B., Butler, S. L., Chervitz, S. A., Gloor, S. L. & Falke, J. J. (2007). 
Use of site-directed cysteine and disulfide chemistry to probe protein 
structure and dynamics: applications to soluble and transmembrane 
receptors of bacterial chemotaxis. Methods Enzymol 423, 25-51. 
41. Shimaoka, M., Lu, C., Palframan, R. T., von Andrian, U. H., McCormack, 
A., Takagi, J. & Springer, T. A. (2001). Reversibly locking a protein fold in 
an active conformation with a disulfide bond: integrin alphaL I domains 
with high affinity and antagonist activity in vivo. Proc Natl Acad Sci U S A 
98, 6009-14. 
 70 
42. Luo, B. H., Takagi, J. & Springer, T. A. (2004). Locking the beta3 integrin 
I-like domain into high and low affinity conformations with disulfides. J Biol 
Chem 279, 10215-21. 
43. Lu, C., Shimaoka, M., Zang, Q., Takagi, J. & Springer, T. A. (2001). 
Locking in alternate conformations of the integrin alphaLbeta2 I domain 
with disulfide bonds reveals functional relationships among integrin 
domains. Proc Natl Acad Sci U S A 98, 2393-8. 
44. Takagi, J., Petre, B. M., Walz, T. & Springer, T. A. (2002). Global 
conformational rearrangements in integrin extracellular domains in 
outside-in and inside-out signaling. Cell 110, 599-11. 
45. Chigaev, A., Buranda, T., Dwyer, D. C., Prossnitz, E. R. & Sklar, L. A. 
(2003). FRET detection of cellular alpha4-integrin conformational 
activation. Biophys J 85, 3951-62. 
46. Takagi, J., Strokovich, K., Springer, T. A. & Walz, T. (2003). Structure of 
integrin alpha5beta1 in complex with fibronectin. Embo J 22, 4607-15. 
47. Weisel, J. W., Nagaswami, C., Vilaire, G. & Bennett, J. S. (1992). 
Examination of the platelet membrane glycoprotein IIb-IIIa complex and its 
interaction with fibrinogen and other ligands by electron microscopy. J Biol 
Chem 267, 16637-43. 
48. Litvinov, R. I., Nagaswami, C., Vilaire, G., Shuman, H., Bennett, J. S. & 
Weisel, J. W. (2004). Functional and structural correlations of individual 
alphaIIbbeta3 molecules. Blood 104, 3979-85. 
 71 
49. Xiong, J. P., Stehle, T., Diefenbach, B., Zhang, R., Dunker, R., Scott, D. 
L., Joachimiak, A., Goodman, S. L. & Arnaout, M. A. (2001). Crystal 
structure of the extracellular segment of integrin alpha Vbeta3. Science 
294, 339-45. 
50. Xiong, J. P., Stehle, T., Zhang, R., Joachimiak, A., Frech, M., Goodman, 
S. L. & Arnaout, M. A. (2002). Crystal structure of the extracellular 
segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. 
Science 296, 151-5. 
51. Beglova, N., Blacklow, S. C., Takagi, J. & Springer, T. A. (2002). Cysteine-
rich module structure reveals a fulcrum for integrin rearrangement upon 
activation. Nat Struct Biol 9, 282-7. 
52. Xiao, T., Takagi, J., Coller, B. S., Wang, J. H. & Springer, T. A. (2004). 
Structural basis for allostery in integrins and binding to fibrinogen-mimetic 
therapeutics. Nature 432, 59-67. 
53. Lau, T. L., Dua, V. & Ulmer, T. S. (2008). Structure of the integrin alphaIIb 
transmembrane segment. J Biol Chem 283, 16162-8. 
54. Lau, T. L., Partridge, A. W., Ginsberg, M. H. & Ulmer, T. S. (2008). 
Structure of the integrin beta3 transmembrane segment in phospholipid 
bicelles and detergent micelles. Biochemistry 47, 4008-16. 
55. Lau, T. L., Kim, C., Ginsberg, M. H. & Ulmer, T. S. (2009). The structure of 
the integrin alphaIIbbeta3 transmembrane complex explains integrin 
transmembrane signalling. Embo J. 
 72 
56. Treutlein, H. R., Lemmon, M. A., Engelman, D. M. & Brunger, A. T. (1992). 
The glycophorin A transmembrane domain dimer: sequence-specific 
propensity for a right-handed supercoil of helices. Biochemistry 31, 12726-
32. 
57. Adams, P. D., Engelman, D. M. & Brunger, A. T. (1996). Improved 
prediction for the structure of the dimeric transmembrane domain of 
glycophorin A obtained through global searching. Proteins 26, 257-61. 
58. Zhu, J., Luo, B. H., Barth, P., Schonbrun, J., Baker, D. & Springer, T. A. 
(2009). The Structure of a Receptor with Two Associating Transmembrane 
Domains on the Cell Surface: Integrin aIIbb3. Mol Cell 34, 234-249. 
 
 
  
 
 73 
 
CHAPTER 4 
 
Structural Characterization of a Disulfide-Linked αIIb/β3 
Cytosolic Domain 
 
INTRODUCTION 
One of the widely studied examples of regulated integrin function is the platelet 
fibrinogen receptor αIIbβ3.1  On a circulating platelet, αIIbβ3 is maintained in a 
resting conformation to prevent deleterious interactions with other circulating cells 
or the vascular endothelium that could cause thrombosis.  Upon vascular injury, 
platelets respond by activating αIIbβ3 to engage soluble ligands that crosslink 
adjacent platelets and form a hemostatic platelet plug.  The activation of resting 
αIIbβ3 proceeds through intracellular “inside-out” signaling cascades that enable 
the cytoskeletal proteins talin and kindlin-3 to bind the β3 cytosolic domain, 
favoring conformations of β3 that displace αIIb from heteromeric αIIb/β3 
interactions in the cytosolic and TM regions.2; 3  Separation of the TM heterodimer 
transduces the intracellular activation signal across the membrane to expose the 
integrin’s extracellular ligand-binding sites.4; 5  Active integrins can then nucleate 
large complexes that initiate “outside-in” signaling cascades including the 
activation of Src kinase which constitutively binds the β3 cytosolic domain.6 
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The β3 cytosolic domain interacts with αIIb, talin, kindlin-3 and Src kinase, 
and the structural basis of these interactions has been previously probed by NMR 
and crystallography.7; 8; 9; 10; 11; 12  Each three-dimensional structure is markedly 
different and it is unclear the extent to which differences reflect discrete 
conformational states or different average structures from a dynamic equilibrium.  
In either case, portions of both the αIIb and β3 cytosolic domains are dynamic,13; 
14; 15; 16 a functional necessity for interactions with multiple different partners, and 
small changes in experimental conditions might shift the dynamic equilibrium 
between different conformations. 
Despite their differences, the N-terminal portion of each β3 structure 
contains a helix that extends to approximately Asp723, and analyses that include 
the β3 TM domain depict this region as an extension of the TM helix.7; 8; 9; 10; 12; 14; 15; 
16  This portion of β3 is important for stabilizing the integrin’s resting state, 
including a putative salt bridge between β3 Asp723 and αIIb Arg995.17  
Downstream of Asp723, published three-dimensional models have divergent 
structure, including regions of β3 that interact with talin, kindlin-3, and Src 
kinase.7; 8; 9; 10; 11; 15  These regions are dynamic, which might account for structural 
differences between various models.14; 15; 16  Similarly, the αIIb cytosolic domain is 
dynamic,13; 16 which might account for differences between its published 
conformations.7; 8; 9; 12; 13; 18  
The structural analysis of the αIIb/β3 cytosolic heterodimer is challenging 
because of its dynamics and because peptides corresponding to the αIIb and β3 
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cytosolic domains do not form a stable complex.  Never-the-less, NMR structures 
of the αIIb/β3 cytosolic interaction have been solved for heteromeric interactions 
observed in equilibrium with other states.8; 9; 12  Notably, Vinogradova et al 
developed a NMR model for the monomeric αIIb and β3 cytosolic domains 
docked using 13 distance restraints derived predominantly from transferred 
NOEs.8  More recently, Lau et al developed a NMR model of the αIIb/β3 TM and 
membrane proximal regions that agrees with many empirical findings, including 
mutagenesis of residues in the TM and cytosolic regions.12  This structure does 
not form a stable complex, rather it interchanges between heteromeric and 
monomeric states, similar to the equilibrium observed for the full length integrin.  
However, the overlapping regions in the Vinogradova and Lau structures are 
substantially different and vary from other reported conformations.8; 9; 12  
Because published NMR models of the αIIb/β3 cytosolic interaction have 
not converged on similar structures in part because the αIIb/β3 interaction is not 
stable, we built a stable αIIb/β3 heterodimer by positioning a disulfide bond in the 
αIIb/β3 interface (figure 14).  This strategy was previously employed to study the 
resting integrin’s αIIb and β3 cytosolic domains, however no interaction was 
observed.16  Since these first generation constructs, we published a model of the 
αIIb/β3 TM heterodimer19 that has been validated by experiments in several 
subsequent reports.  Notably the model was confirmed by cysteine scanning 
mutagenesis near the TM heterodimer’s N-terminus in which cysteine mutations 
at the model’s interface could crosslink the αIIb and β3 subunits in the full length 
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  Fig 14.  Design of the disulfide-linked αIIb/β3 cytosolic heterodimer.  (top) The 
sequences of the αIIb and β3 subunits; each subunit includes a SPE helix cap followed by 
the cysteine C used for crosslinking.  After the cysteine, the αIIb and β3 cytosolic 
domains consist of residues W715-E1008 and L713-T762, respectively.  Additionally, 
the β3 subunit contained an upstream histidine tag that was used during purification 
steps.  The cysteines were positioned based on the αIIb/β3 interface depicted in the 
Monte Carlo model from Chapter 3.  (bottom) A cartoon depicting the position of the 
engineered disulfide bond and its relation to other integrin domains including the αIIb 
Arg995-β3 Asp723 salt bridge, which is postulated to stabilize the integrin’s resting 
conformation, and β3 cytosolic domains that bind talin, kindlin-3, and Src kinase. 
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integrin.20  Building upon this finding, cysteines were positioned in the model’s C-
terminal interface, which is closer to the cytosolic domains, to crosslink a NMR 
construct consisting of the αIIb and β3 cytosolic domains.  The disulfide bond 
enforces 1:1 stoichiometry and eliminates many conformations that are 
inaccessible to the native integrin. 
The construct was dissolved in dodecyl phosphocholine (DPC) micelles to 
mimic the membrane environment and analyzed at 37º with physiological 
protonation (pH = 6.0).  The αIIb and β3 subunits had different circular dichroism 
(CD) spectra before and after reducing the cysteine crosslink which 
demonstrates that they interact when constrained by a disulfide bond.  The 
analysis of chemical shift suggests that β3 interacts with αIIb along the face of a 
helix containing β3 residues Lys716, Ile719, and Asp723, similar to the published 
structure of the αIIb/β3 TM heterodimer.  However there were no NOE 
interactions between αIIb and β3 downstream of the disulfide bond, the αIIb 
subunit had no unique conformation, and the αIIb interface could not be defined.  
Taken together, these results suggest a physical yet likely disordered interaction 
between a β3 helix and a natively unstructured region of αIIb.   
The β3 solution structure was solved with the disulfide-linked αIIb subunit 
to enforce the conformation it has in the resting integrin.  The structure consists 
of an N-terminal helix and two additional cytosolic helices, similar to the solution 
structure of the monomeric β3 TM and cytosolic regions.15  Portions of the β3 
interfaces that bind talin had conformations that are similar to those observed in 
  
 
 78 
structures of β3/talin complexes,10; 11 suggesting that the β3 cytosolic domain is 
pre-organized to bind talin.  In contrast, the β3 NPXY motif that binds kindlin-3 
resides in an α-helix, inconsistent with known interacting conformations for NPXY 
motifs.  However this helix was highly dynamic and its NPXY motif contained a 
number of violated NOEs indicating the helical conformation exists in equilibrium 
with other states.  Lastly, Src kinase constitutively binds the last three residues of 
the β3 cytosolic domain RGT,6 and this region was found to be unstructured and 
dynamic, possibly primed for interactions with Src. 
Finally, different portions of the β3 structure were analyzed with a 
membrane insertion potential to define their calculated membrane embedding.21  
The N-terminal helix embedded in a membrane spanning orientation, as 
expected for a TM helix, and the two cytosolic helices partitioned into the 
membrane/cytosol interface, suggesting amphiphilic character.  Notably, the two 
cytosolic helices contain residues that interact with talin and kindlin-3, and 
membrane embedding can compete with these interactions.  Thus the calculated 
membrane embedding of the β3 structure defines conformations of the resting 
integrin that are inaccessible to either talin or kindlin-3.  
 
MATERIALS AND METHODS 
Plasmid Constructs 
The αIIb cytosolic domain was cloned into a pET-16b vector (Novagen) as a C-
terminal fusion with the designed protein α3D, a small, highly stable protein that 
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expresses well in bacteria.22  A linking region was engineered to include proline 
to disrupt secondary structure, two glycines as a flexible spacer, and a thrombin 
cleavage site.  The αIIb construct immediately followed including a SPE N-
terminal helix cap and the cysteine used to crosslink the αIIb and β3 subunits.  
The construct’s sequence is:  α3D-P-GG-LVPR-SPE-C-WKVGFFKRNRPPL 
EEDDEEGE.  The italicized residues were used for expression, purification, and 
crosslinking while the non-italicized sequence corresponds to αIIb residues 
Trp988-Glu1008. 
 The β3 cytosolic domain was cloned into the pET-15b vector (Novagen) as 
a C-terminal fusion to a histidine tag.  This construct also includes a SPE N-
terminal helix cap followed by the cysteine used for crosslinking the αIIb and β3 
subunits.  The sequence of the β3 peptide is: MGSSHHHHHHSSGLVPRGSHM-
SPE-C-LIWKLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT.  
The italicized residues were used for expression, purification, and crosslinking 
while the non-italicized sequence corresponds to β3 residues Leu713-Thr761.  
All constructs were confirmed by DNA sequencing. 
 
Expression and Purification 
The α3D-αIIb fusion protein was expressed in E. coli strain BL21.  Cells were 
grown to an OD600 of 0.8 AU in M9 minimal media supplemented with 200 µg/ml 
Ampicillin, then induced with 1 mM IPTG for four hours at 37ºC.  The media 
contained 13C glucose and/or 15N ammonium chloride to label the peptide for 
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NMR experiments.  The cells were pelleted, resuspended in 50ml PBS per liter 
culture, and lysed with three freeze-thaw cycles.  Lysozyme was added to 100 µg 
per ml and the lysate was sonicated to further break apart the bacterial 
membrane.  The cell debris was pelletted and discarded.  The supernatant was 
heated to 70º C for 30 minutes to denature soluble proteins, then cooled to 4º C 
which precipitates denatured proteins while leaving the α3D-αIIb fusion protein in 
solution.  The mixture was centrifuged to remove the precipitate and the 
supernatant was dialyzed into PBS buffer at pH 7.5.  Absorbance at 280nm was 
used to approximate the protein concentration, and the fusion protein was 
cleaved overnight with 10 units of thrombin per milligram protein.  The cleaved 
peptide was reduced with excess TCEP and further purified by reverse phase 
HPLC.  Finally, the eluted protein was lyophilized and stored at -80ºC.  This 
protocol generates >10mg of the αIIb cytosolic domain per liter culture.  The 
product’s molecular weight was confirmed by mass spectroscopy. 
 Likewise, the β3 peptide was expressed in E. coli strain BL21.  The cells 
were grown to an OD600 of 0.8 AU in M9 minimal media supplemented with 200 
µg/ml Ampicillin then induced with 1 mM IPTG for four hours at 37ºC.  The media 
contained 13C glucose and/or 15N ammonium chloride to label the peptide for 
NMR experiments.  The β3 peptide was purified on Ni-NTA resin using the 
QIAExpressionist protocol for denaturing conditions (Qiagen).  Eluted β3 peptide 
was reduced with excess TCEP and further purified by reverse phase HPLC.  
Purified β3 was lyophilized and stored at -80ºC.  The histidine tag was not 
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removed from the β3 cytosolic domain, and this protocol makes 10mg of the β3 
construct per liter culture.  The product’s molecular weight was confirmed by 
mass spectroscopy. 
 
Coupling α IIb and β3 
The β3 peptide was dissolved at 5mg/ml in 2M guanidine, buffered to pH 6.0 with 
50mM MES.  The reduced β3 cysteine thiol was activated for coupling with 5-fold 
molar excess 2-2'dithio-bis-(5-nitropyridine) dissolved DMSO.23  Activated β3 was 
purified from excess 2-2'dithio-bis-(5-nitropyridine) on a PD-10 column using 5% 
acetic acid as the mobile phase.  The purified β3-thio-nitropyridine was 
lyophilized.  Activated β3 was reacted with a slight molar excess of reduced αIIb 
in guanidine-MES buffer, pH 6.5 for several hours.  Crosslinked αIIbβ3 was 
purified from the reaction mix using reverse phase HPLC and the eluted protein 
was lyophilized.  The heterodimer’s molecular weight was confirmed by mass 
spectroscopy. 
 
Circular Dichroism (CD) Spectroscopy 
CD spectra of 10µM disulfide-linked αIIb/β3 heterodimer in 5mM sodium 
phosphate buffer containing 10mM DPC, pH 6.5 was recorded in a 1mm path 
length cell before and after the addition of the reducing agent TCEP.  TCEP was 
added from a 0.5mM stock solution, pH 6.5 at 5-fold molar excess.  As a control, 
buffer without reducing agent was added to a similar sample. 
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  Fig 15.  SDS-PAGE analysis of a NMR sample, crosslinked αIIb/β3, and the same 
sample with the addition of reducing agent.  The NMR sample has a molecular weight 
that corresponds to αIIb/β3, and it is composed of subunits with molecular weights that 
correspond to the individual αIIb and β3 peptides.  Samples were further validated using 
a battery of more rigorous techniques including mass spectroscopy. 
 
NMR Spectroscopy 
The disulfide linked αIIbβ3 heterodimer, as isolated from HPLC, was dissolved at 
1mM in 5mM sodium phosphate buffer containing 100mM perdeuterated dodecyl 
phosphocholine (DPC, Cambridge Isotope Laboratories), 10% deuterium oxide, 
and 0.02% sodium azide as a preservative.  The pH was adjusted to 6.0 with 
sodium hydroxide.  DSS was added to some samples at 1mM to reference proton 
αIIb/β3 
β3 
αIIb 
αIIbβ3 + reducing agent protein standard 
crosslinked αIIb/β3 
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chemical shifts.  Samples were analyzed at 37ºC on a 750 MHz NMR 
spectrophotometer equipped with a Varian probe.  A standard battery of 
experiments allowed us to identify the proton, carbon, and nitrogen resonances 
for most backbone, aliphatic, phenyl, phenol, indole, imidazole, amide, and 
guanidinium groups.24 
 
β3 Structure Calculation 
NOE distance restraints were derived from a 3D 15N-editied NOESY, 3D aliphatic 
13C-edited NOESY, 3D aromatic 13C-edited NOESY, and a 4D 13C-edited NOESY.  
Hydrogen bonding distance and geometry restraints25 were implemented for the 
backbone amides of β3 residues Leu713-Ile721 which are protected from 
hydrogen-deuterium exchange and predicted to reside in an α-helix.  Additionally, 
the φ and ψ dihedrals of β3 residues Ile714-His722, Phe727-Arg736, and Tyr747-
Ile757 were restrained based on the statistical analysis of chemical shift using 
the TALOS algorithm26 which predicts that these regions are helical.  For other 
residues, chemical shift restraints were implemented for their Cα and Cβ atoms,27 
and chemical shift restraints were implemented for every Hα atoms.28  Finally, 
HN-Hα J-couplings were measured in the HNHA experiment and implemented as 
φ dihedral angle restraints for helical regions or J-coupling restraints for regions 
with less defined secondary structure which restricts the φ dihedral to 1-4 
possible angles.29 
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 6000 structures were calculated with XPLOR-NIH using a protocol similar 
to the anneal.py example script that comes with the software package.30; 31  The 
top 60 structures were refined using the same protocol with increased weighting 
for proper bond geometries. The top 20 refined structures were aligned over 
residues Leu713-Ala735, which converged on a similar conformation, and this 
structural ensemble will be submitted to the protein databank upon publication. 
 
Hydrogen-deuterium exchange (HDX)  
HDX was performed by re-dissolving a lyophilized NMR sample in deuterium 
oxide.  Exchange was monitored in the 15N HSQC experiment and the first 
timepoint was available at 11 minutes. 
 
Calculated Membrane Insertion 
β3 residues 713-735 and 744-762 from the calculated structure were embedded 
in the membrane using a grid search that sampled membrane depth and two 
orthogonal rotations.  Energies were calculated using the E(z) potential,32 and the 
conformations with the best E(z) energies are depicted in figure 22. 
  
RESULTS 
Design of the disulfide-linked α IIb and β3 cytosolic domains 
The NMR construct was engineered to enforce the interface observed in the 
Monte Carlo model from Chapter 3.  Specifically, the TM residues Met987 in αIIb 
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and Leu712 in β3 occur at the model’s interface and these positions were 
substituted with cysteine to crosslink the NMR construct (figure 14).19  The model 
predicts an ideal disulfide bond between the two cysteines, and the disulfide 
bond contains three torsional angles that can accommodate conformational 
adjustment and dynamics.  The subsequent NMR structure of the αIIb/β3 TM 
heterodimer confirmed this model and that Met987 and Leu712 occur at the 
αIIb/β3 TM interface.12 
Additionally, N-terminal SPE helix caps were added upstream of each 
cysteine to enforce helical structure that might be propagated from the TM 
helices to the cytosolic domains.  The N-terminal portion of the β3 subunit was 
helical, however, the αIIb subunit had no stable secondary structure, consistent 
with the conformations observed in two recent NMR analyses of the αIIb and β3 
TM and membrane proximal regions in phospholipid bicelles.13; 14  Finally, the 
construct was characterized with a histidine tag attached to the N-terminus of β3 
which was used in purification steps. 
 
Circular dichroism spectroscopy demonstrates that the α IIb and β3 
cytosolic domains interact 
We first used circular dichroism (CD) spectroscopy to determine whether 
crosslinking the αIIb and β3 cytosolic domains affects their structure.  The CD 
spectrum of disulfide-linked αIIb/β3 was dominated by signals at 190, 208, and 
222 nm which is characteristic of helical secondary structure (figure 16).  When 
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the disulfide bond was reduced, these signals had smaller magnitudes which 
suggests the disulfide-linked heterodimer has more helical content than its 
component monomers.  The different CD spectra demonstrate that αIIb and β3 
interact when constrained by the engineered disulfide bond. 
 
  Fig 16.  The circular dichroism (CD) spectrum of the disulfide-linked αIIb/β3 cytosolic 
heterodimer (solid line) was dominated by signals at 190, 208, and 222 nm, characteristic 
of helical secondary structure. When the αIIb and β3 subunits were separated by 
reducing the disulfide bond, the monomers had a different CD spectrum (dotted line) 
which demonstrates that αIIb and β3 interact when constrained by the disulfide bond, and 
that this interaction affects their structure. 
 
Cα  chemical shift indicates that crosslinking the α IIb cytosolic domain to 
β3 induces conformational changes in the β3 subunit 
To further probe the interaction between αIIb and β3, we identified differences in 
Cα chemical shift between the disulfide-linked αIIb/β3 heterodimer and a 
 
  molar ellipticity 
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previously characterized β3 monomer.  Cα chemical shift is an NMR parameter 
that is sensitive to protein secondary structure and protein interactions.33  Prior 
analysis of Cα chemical shift found that this parameter demarcated three helical 
regions in a construct consisting of the monomeric β3 TM and cytosolic 
domains.15  Similarly, this parameter demarcates three helical regions of β3 in the 
disulfide-linked αIIb/β3 heterodimer (figure 17).  However, there were significant 
differences in Cα chemical shift between the β3 monomer and the αIIb/β3 
heterodimer encompassing twelve residues that define the N-terminal β3 helix in 
the heterodimer construct.  This region includes residues that are considerably 
downstream of the disulfide bond and demonstrates that the disulfide bond 
enforces other cytosolic αIIb/β3 interactions.  Lastly, the Cα chemical shifts of 
αIIb displayed no preference for helical secondary structure, consistent with a 
recent NMR structure of this region that includes its neighboring TM domain 
embedded in phospholipid bicelles.13 
 
Aliphatic chemical shifts define a β3 interface that interacts with α IIb  
The β3 interface that interacts with αIIb was identified by comparing the 13C 
HSQC spectra of the disulfide-linked αIIb/β3 heterodimer and the reduced 
monomers.  Reducing the disulfide bond altered side chain chemical shifts in β3 
residues Lys716 and Ile719 which indicates that these residues interact with αIIb 
(figure 18).  This interface resides on a face of the N-terminal β3 helix that 
includes Asp723 (figure 21), consistent with predictions that Asp723 is at the 
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αIIb/β3 interface.17  Additionally, it is consistent with the β3 interfaces reported in 
previous NMR structures of the αIIb/β3 cytosolic interaction including the 
structure of the αIIb/β3 TM heterodimer that found 7 NOEs between Ile719 and 
different αIIb residues.8; 9; 12 
 
  Fig 17.  Cα resonance is an NMR parameter that is sensitive to protein secondary 
structure and protein interactions.  This parameter demarcated three helical regions of β3 
in the disulfide-linked heterodimer, similar to a previous structural analysis of the β3 
monomer; helices end when the Cα resonance approach its random coil value (Cα 
resonance – Cα random coil = 0).  The αIIb subunit affects Cα resonances over the first 
twelve residues of β3 in the disulfide-linked construct, suggesting that the disulfide bond 
enforces additional interactions in this region. 
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  Fig 18.  Side chain chemical shifts are sensitive to protein interactions, and the chemical 
shifts of aliphatic atoms can be visualized in the 13C HSQC spectrum.  The blue and 
purple signals correspond to aliphatic atoms in the disulfide-linked αIIb/β3 heterodimer, 
and the red and green overlay corresponds to the αIIb and β3 monomers.  The chemical 
shifts of β3 residues Lys716 and Ile719 change when the disulfide bond is reduced which 
suggests these residues interact with αIIb.  (Purple and green signal is folded in the 
carbon dimension by 20 ppm). 
 
Analysis of NOEs at the α IIb/β3 heterodimer interface 
The analysis of aliphatic chemical shifts demonstrates that β3 residues Lys716 
and Ile719 interact with αIIb, however these residues displayed no interchain 
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NOEs with αIIb.  Furthermore, the only NOEs between the αIIb and β3 subunits 
occur near the disulfide crosslink.  Upon first inspection, this result appears to 
conflict with published NMR structures that found NOEs between the αIIb and β3 
subunits.  These analyses relied on innovative strategies to detect interchain 
NOEs, including transferred NOE experiments8 and selective labeling,12 because 
the heterodimer could not be isolated from conformations that otherwise masked 
αIIb/β3 interactions.  However our experimental design effectively isolates the 
heterodimer by positioning a covalent tether at its interface.  In this construct, a 
stable interface would be readily defined by standard NOE experiments, and we 
employed a 4D NOESY that can unambiguously identify NOEs including every 
interchain NOE observed in the published structure of the αIIb/β3 TM 
heterodimer.12  The lack of interchain NOEs at the β3 interface suggests that the 
αIIb/β3 cytosolic interaction is intrinsically disordered, at least in the disulfide-
linked construct described here. 
 Also, the guanidine group of αIIb Arg995 is postulated to form a salt bridge 
with β3 Asp723,17 and our experimental conditions allowed us to unambiguously 
assign guanidine resonances (figure 20) and detect NOEs between the guanidine 
groups and other adjacent protons.  However the Arg995 guanidine protons did 
not have any NOEs with the β3 sidechain.  This result is consistent with an 
intrinsically disordered interface, and the interaction likely reflects a solvent 
exposed acid/base pair that does not have a unique conformation, but could still 
impart some specificity between the αIIb and β3 subunits.34; 35  
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  Fig 19. The H-15N NOE intensity correlates with backbone dynamics.  β3 residues 
Leu713-Glu726 and αIIb residues Val990-Asn996 undergo similar dynamics which 
suggests that these regions interact.  Downstream residues are increasingly dynamic, 
including two β3 helices.  Additionally, the β3 RGT motif is dynamic which suggests it 
is accessible to cytosolic proteins. 
 
Backbone dynamics are consistent with an α IIb/β3 interaction 
Since there were no NOEs between the αIIb and β3 subunits, suggesting an 
intrinsically disordered interaction, we determined whether the construct’s 
dynamics were consistent with an αIIb/β3 interaction.  The strength of the H-15N 
NOE correlates with each residue’s order parameter and it was analyzed to 
qualitatively assess the dynamics of the disulfide-linked construct.36; 37  The αIIb 
  
 
 92 
residues Val990-Asn996 and β3 residues Leu713-Glu726 have similar H-15N 
NOE intensities which supports our finding that these regions interact (figure 19).  
However, the αIIb intensities trended toward higher dynamics, consistent with a 
natively unstructured region of αIIb interacting with a structured, helical portion of 
β3.  Residues downstream of this interacting region were increasingly dynamic in 
both the αIIb and β3 subunits. 
 
Stability of β3 secondary structure determined by hydrogen-deuterium 
exchange 
The increasing dynamics in β3 corresponds to increasingly divergent structure in 
published models of β3, and since the β3 subunit in disulfide-linked αIIb/β3 is 
predominantly helical, hydrogen-deuterium exchange (HDX) was used to 
determine whether dynamics can account for differences in helical content.  We 
performed HDX by dissolving a lyophilized NMR sample in deuterium oxide and 
identifying amide protons that do not exchange with deuterium, indicating they 
are likely to form stable hydrogen bonds in a helix.  The first β3 helix was 
protected from exchange which demonstrates it has stable helical structure 
(figure 20).  In contrast, β3’s second two helices were not protected from 
exchange which demonstrates they have transient helical structure.  These 
results suggest that dynamics might account for differences between β3 
structures reported in the literature which each depict an N-terminal helix, but 
have varying degrees of helical content downstream of Asp723. 
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  Fig 20.  The 15N HSQC detects backbone amines, and in some cases, the arginine 
guanidine group.  When the αIIb/β3 heterodimer is transferred from water to deuterium 
oxide, most of the protons exchange with deuterium but the red peaks corresponding to 
β3 residues Ile714-Ile721 are protected from exchange which suggests they form stable 
hydrogen bonds in a helix.  In contrast, other helical regions exchange rapidly with 
deuterium, suggesting they are dynamic. 
 
β3 structure calculation 
NMR structure calculations were used to further define the three-dimensional 
conformations of αIIb and β3 based on NOEs, the statistical analysis of chemical 
shift, and HN-Hα J-couplings.  However calculations did not converge on a 
unique conformation for the αIIb subunit because it does not contain secondary 
structure and has incompatible NOEs, presumably due to a dynamic equilibrium 
between multiple conformations.  Additionally, residual dipolar couplings (RDCs) 
were measured for use as structural restraints, however they did not aid structure 
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calculation in part because the structure is dynamic and the RDC alignment 
tensors vary throughout the construct.  This result is consistent with a natively 
unstructured conformation for αIIb. 
 In contrast with αIIb, the β3 subunit contained NOE patterns that defined 
three helical regions.  Additionally, NOEs defined the orientation of the first two 
helices in the construct.  However many unambiguous NOEs are violated in the 
calculated structure which define (1) alternate rotamer conformations, (2) 
alternate conformations for the loop linking the last two helices, and (3) alternate 
conformations for the NPXY motif that terminates the last helix.  These violated 
NOEs were identified in initial structure calculations and eliminated from the 
calculations used for the structural ensemble presented here to reduce 
contradictory energy gradients that might otherwise falsely restrain the structure.  
The quality of the structural ensemble was assessed using PROCHECK-NMR38 
and 86.8% of the residues have conformations in the “most favored” region of 
Ramachandran space; a structure with ideal statistics has >90% but <100% of its 
residues in the most favored region, and the β3 structural ensemble has near 
ideal Ramachandran statistics when the loop regions are not considered. 
 
The β3 cytosolic domain is primed for interactions with talin, kindlin-3, and 
Src kinase 
The structure and dynamics of β3 sequence motifs that interact with talin, kindlin-
3, and Src kinase were further analyzed to determine whether they could assume 
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conformations that are compatible with binding (figure 21).  First, motifs that bind 
the cytoskeletal protein talin were compared to crystal and NMR structures that 
depict β3/talin interactions.10; 11  Several β3 residues are critical for talin binding 
 
Table V.  Summary of the β3 structure statistics 
NOE restraints   
residue 1, 2 NOE classification number of NOEs 
i to i self 87 
i to i+1 neighbor 355 
i to i+2 turn/loop 57 
i to i+3/4 helix 360 
i to i>4 turn/loop 29 
     total  888 
     NOEs per residue  17.8 
     violations > 0.5 Å  1* 
   
Dihedral angle restraints   
TALOS φ/ϕ  30/30 
HN-Hα φ  16 
     violations > 10º   0 
   
Chemical shift restraints   
Cα/Cβ   19/19 
Hα   50 
   
HN-Hα J coupling 
restraints 
 11 
   
Hydrogen bond O…H-N 
distance restraints 
 5 
   
Residues in most favored 
regions of 
Ramachandran space 
  
86.8% 
*107 NOEs were omitted from the structure calculation and 
violated by the final structural ensemble. 
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  Fig 21.  The β3 NMR structural ensemble was divided into two regions consisting of 
residues Leu713-Trp739 and Asp740-Thr762 and the Cα atoms of each region were 
aligned.  Domains that interact with αIIb, talin, kindlin-3, and Src kinase are circled and 
side chains that make up the interfaces are depicted as spheres.  Also, the two β3 NPXY 
motifs are colored brown and the RGT motif that binds Src kinase is colored 
blue/green/red.  Notably, the analysis of chemical shift suggests that Lys716 and Ile719 
interact with αIIb, and these positions reside on the same face of a β3 helix as Asp723, 
which is postulated to form a salt bridge with αIIb.  
 
including Trp739 and a β3 NPXY motif consisting of residues Asn744, Pro745, 
Leu746, and Tyr747.3; 11  Every Trp739 indole resonance was unambiguously 
assigned and probed in 13C and 15N NOESY experiments edited for indole 13C/15N 
frequencies.  Several protons displayed NOEs at the solvent resonance, but 
there were few NOEs with other atoms in the construct.  This lack of interaction is 
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apparent in the structural ensemble and quite rare for a tryptophan indole,39 
suggesting that Trp739 is both accessible and primed for interaction.  Next, the 
structure of the β3 NPXY motif that binds talin was defined by NOEs, the analysis 
of chemical shift, and J-coupling which predict that the NPXY is a N-terminal helix 
cap that nucleates an α-helix.  The N-terminal helix cap is similar to 
conformations observed in previous structures of the β3/talin interaction,11 
suggesting that the β3 NPXY motif pre-organized to bind talin, however the 
capping interaction has never been described for an NPXY motif and will be 
discussed in further detail below.  Finally, a previous NMR analysis found that 
talin interacts with a helical portion of β3 containing Phe727 and Phe730,10 and 
this portion of β3 is helical in the structure presented here, suggestion that this 
interface is pre-organized to bind talin as well. 
 The β3 interface that binds the cytoskeletal protein kindlin-3 has been 
defined as a NPXY motif consisting of β3 residues Asn756, Ile757, Thr758, and 
Tyr759 and possibly the upstream residue Ser752,2 although the kindlin-3 
interface has not been as extensively examined as the talin interface and there 
are no experimental structures depicting the interaction.  The kindlin-binding 
NPXY motif terminates the final β3 helix in the structure presented here, which is 
not a known interacting conformation.  However, this region of β3 is highly 
dynamic and contains NOEs that are incompatible with a single conformation 
which suggests that the NPXY motif exists in equilibrium between conformations 
have different affinities for kindlin-3. 
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 Lastly Src kinase binds the last three C-terminal residues of β3 Arg760, 
Gly761, and Thr762 which are called an RGT motif,6 although the structural basis 
for this interaction has not been described in the literature.  Our NMR analysis 
found that the RGT motif is highly dynamic (figure 19), does not have a unique 
conformation, and does not interact with other portions of the construct which 
suggests it is accessible and primed for interactions with Src. 
 
NOEs define the β3 NPXY Motif as a N-terminal Helix Cap 
An NPXY motif consists of residues Asn-Pro-X-Tyr and this sequence binds 
phosphotyrosine binding (PTB) domains upon phosphorylation (X can be any of 
several different amino acids).40  Talin contains a novel PTB domain that binds 
the unphosphorylated β3 NPXY motif consisting of residues Asn744, Pro745, 
Leu746, and Tyr747.  Previous structures of NPXY motifs found that they adopt a 
type I β-turn when bound to a PTB domain, however the crystal structure of β3 
bound to talin is consistent with both a type I β-turn and a N-terminal helix cap.11  
In the NMR structure of the disulfide-linked αIIb/β3 heterodimer described here, 
NOEs define a conformation that is most consistent with a N-terminal helix cap 
that nucleates the second cytosolic helix in β3, suggesting the conformation of 
the β3 NPXY motif is pre-organized to bind talin thereby minimizing its entropic 
cost of binding (figure 23).   
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Calculated membrane insertion predicts the regions of β3 that interact with 
talin and kindlin-3 partition into the membrane.  
The membrane embedding of the β3 subunit was calculated using a membrane 
insertion potential.32  The N-terminal helix partitions into the bilayer in a 
membrane spanning orientation which suggests it is an extension of the TM helix 
(figure 22).  Additionally, the two downstream helices partition into the membrane 
in amphiphilic conformations, derived in part from hydrophobic residues Phe727 
and Phe730 in one helix and Tyr747 in the other which also make up portions of 
the interfaces that interact with talin.10; 11  Intriguingly, the membrane embedding 
of these helices would sequester them from interactions with talin and kindlin-3.  
This finding suggests that the β3 cytosolic domain exists in equilibrium between a 
membrane bound conformations that cannot bind talin or kindlin-3 and 
accessible, solvent exposed conformations.    
 
DISCUSSION AND CONCLUSIONS 
Previous NMR analyses hypothesized that the native αIIb/β3 interface would 
stabilize a complex between peptides corresponding to their cytosolic and/or TM 
domains, however a stable 1:1 complex has never been observed.  Based on 
these findings, a disulfide-linked αIIb/β3 cytosolic domain was engineered that 
has 1:1 stochiometry and enforces an interface observed in models of the αIIb/β3 
TM heterodimer.  The αIIb and β3 cytosolic domains interact in the construct and 
their interface is intrinsically disordered, consisting of a natively unstructured 
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region of αIIb interacting with a β3 helix.  The structure on the β3 subunit was 
calculated, and we further characterized β3 interfaces that interact with αIIb, talin, 
kindlin-3, Src kinase, and the cell membrane. 
 
 
  Fig 22.  Portions of the calculated β3 structure were oriented using a membrane 
insertion potential.  The first helix in the β3 construct embedded in a membrane-spanning 
orientation and two subsequent helices embedded in amphiphilic orientations.  The 
membrane-embedding of Phe727, Phe730, and Tyr747 would prevent interactions with 
talin and the membrane embedding of Tyr759 would prevent interactions with kindlin-3. 
 
Prior analysis of the integrin cytosolic domains 
The resting integrin’s cytosolic heterodimer has been probed by several NMR 
analyses.8; 9; 16; 41  Notably, Vinogradova et al. observed transferred NOEs 
between peptides corresponding to the integrin’s cytosolic domains and 
calculated a structure based on these interactions.8  Several features of the 
resting integrin support this model, however transferred NOEs require a 
kinetically unstable interaction, so they are more likely to reflect non-specific 
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interactions than the standard NMR experiments used for protein structure 
determination. 
Vinogradova’s research suggests that the integrin’s TM heterodimer is 
necessary to stabilize the cytosolic heterodimer, and two strategies attempted to 
account these interactions.  First, Ulmer et al. engineered several constructs with 
N-terminal disulfide bonds and coiled coils that fixed the αIIb and β3 cytosolic 
domains in a parallel orientation with 1:1 stoichiometry, however no heteromeric 
interaction was observed, suggesting that the αIIb and β3 cytosolic domains do 
not interact or that the upstream constraints failed to approximate native 
interactions.16  To account for native TM domain interactions, Li et al. analyzed 
peptides containing both the cytosolic and TM domains of αIIb and β3, however 
the peptides formed homo-oligomers instead of heterodimers.41  More recently, 
Lau and coworkers found experimental conditions that favored heteromeric TM 
associations and developed an NMR model for this interaction that agrees well 
with mutagenesis results.12  However this analysis only considered a fraction of 
the αIIb and β3 cytosolic domains and did not report on their dynamics. 
We combined prior strategies to stabilize the αIIb/β3 heterodimer by 
including a portion of the αIIb and β3 TM regions and introducing a disulfide-
crosslink at the TM heterodimer interface.  This construct is the first stable 
αIIb/β3 cytosolic heterodimer that has an observable αIIb/β3 interaction, and it 
allowed us to define the structure and dynamics of the αIIb and β3 cytosolic 
domains in a single conformation that approximates the integrin’s resting state. 
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The α IIb/β3 cytosolic interface is intrinsically disordered 
CD and NMR analyses revealed that the engineered disulfide-crosslink in the 
αIIb and β3 TM region enforced an interaction between the αIIb and β3 cytosolic 
domains.  However while the chemical shift differences of the β3 Lys716 and 
Ile719 side chains demonstrated that these residues interacted with αIIb, they 
displayed no NOEs with αIIb suggesting the interaction is dynamic on the 
millisecond timescale.  Also, we found that the αIIb subunit had no stable helical 
structure, consistent with a previous NMR structure of this region in 
phospholipids bicelles.13  Never-the-less, αIIb interacted with β3 over the length 
of approximately twelve residues including portions of the β3 helix that are 
significantly downstream from the TM crosslink.  The interaction suggests that 
the αIIb subunit does not have random structure, instead it has conformational 
bias toward structures that interact with β3.  This type of intrinsically disordered 
interaction is important for proteins that couple multiple different signaling events 
to an overall equilibrium.  For the integrin, an intrinsically disordered interface 
allows it to couple many different cytosolic events to the overall resting-active 
equilibrium.  The integrin’s equilibrium can be affected by talin and kindlin 
binding,2; 3 phosphorylation,42 and proteolysis,43 and the cytosolic domains convert 
this dynamic information into a binary signal: resting or active. 
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The α IIb Arg995-β3 Asp723 salt bridge is a solvent exposed interaction 
Mutations affecting cytosolic residues αIIb Arg995 and β3 Asp723 activate the 
integrin, but reciprocal mutations Arg995Asp and Asp723Arg restore the 
integrin’s resting state.17  This result is widely interpreted as evidence that a salt 
bridge between Arg995 and Asp723 stabilizes the resting conformation.  The 
current analysis is consistent with the Arg995-Asp723 salt bridge and provides 
some evidence supporting the interaction.  First, Asp723 is at the β3 interface 
that interacts with αIIb, and second, the regions that contain Arg995 and Asp723 
undergo similar dynamics.  However, HDX suggests that Asp723 is solvent 
exposed, so any interaction between Asp723 and Arg995 would be more similar 
to an electrostatic interaction on the surface of a protein than a buried interaction 
that might have a single stable conformation.  Solvent exposed electrostatic 
interactions are dynamic and can be very important for specificity without locking 
an acid/base pair into a single conformation.34; 35  This type of interaction is 
especially useful for orienting a dynamic interface without providing a driving 
force that could independently stabilize the αIIb/β3 complex. 
 
The β3 NPXY motif is a N-terminal helix cap 
Previous structures of NPXY motifs have been characterized as type I β-turns40 
and have slightly different structure than the β3 NPXY motif which was found to 
be a N-terminal helix cap that nucleates an α-helix.  The capping conformation is 
similar to previous structures of talin bound to β3, PIPKγ, and a β3/PIPKγ chimera 
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that are consistent with both β-turns and N-terminal helix capping motifs, 
however the NPXY motifs in these structures do not nucleate helices.10; 11; 44  It is 
possible that talin binding favors unfolded conformations of the β3 helix, which 
might function to expose the second NPXY motif to bind kindlin-3. 
 
The membrane embedding of β3 prevents interactions with talin and 
kindlin-3 
The E(z) membrane depth potential predicts that the β3 cytosolic domain is 
amphiphilic and residues Phe727, Phe730, and Tyr747 partition into the cell 
membrane (figure 22), consistent with previous NMR experiments that observed 
NOEs between DPC and Tyr747.7  Membrane insertion sequesters these 
residues from cytosolic proteins so they cannot bind talin as depicted in 
structures of the β3/talin complex, and the membrane embedding of the kindin-3 
binding site would prevent β3 interactions with kindlin-3 as well.  However the 
cytosolic helices exist in dynamic equilibrium with unfolded states that likely 
correspond with solvent exposed conformations.  Amphiphilic domains that 
switch their degree of membrane exposure are commonly found proximal to TM 
helices in proteins including voltage gated channels,45; 46 phospholamban,47 and 
the M2 proton channel from influenza.48; 49  Recently, the cytosolic domain of the 
T-cell receptor’s CD3ε subunit was found to bind membrane which sequesters 
aromatic residues from cytosolic proteins including a tyrosine in its NPXY motif.50  
When the T-cell receptor is activated, the amphiphilic domain is 
  
 
 105 
 
Fig 23.  Analysis of talin 
binding to the β3 cytosolic 
domain.  (a)  The analysis 
of chemical shift suggests 
that β3 residues Lys716 
and Ile719 interact with 
αIIb, and these residues lie 
along the same face of the 
β3 helix that includes 
Asp723, which is 
postulated to form a salt 
bridge with αIIb residue 
Arg995.  Also, prior 
structural analysis of β3 and talin depict interfaces that contain β3 residues Phe727, 
Phe730, Trp739, and Tyr747. (b)  Talin interacts with a β3 NPXY motif, and the 
calculated β3 structure suggests that the NPXY motif is a N-terminal helix cap that 
nucleates an α-helix.  (c and d)  Talin (orange) cannot bind the β3 structure reported here 
because it is amphiphilic and embeds in the membrane.  When β3 is modeled as a helix, 
similar to a previous NMR model that depicts a β3/talin interaction, the αIIb interface 
resides on the same face of the β3 helix as the talin interface.  These findings are 
consistent with the hypothesis that talin shifts the integrin equilibrium toward active 
conformations and displaces αIIb from heteromeric interactions with β3. 
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 released from the membrane and binds signaling proteins.  The β3 cytosolic 
domain might have analogous interactions with membrane where the cytosolic 
domain favors a membrane associated conformation in the resting integrin and 
talin and/or kindlin-3 shifts the conformation toward a solvent exposed state. 
 
Talin binding to the β3 cytosolic domain requires a conformational change 
The membrane embedding of the β3 cytosolic domain is partially mediated by a 
kink near the membrane/cytosol interface.  However, the kink adopts a helical 
conformation in an NMR structure of the β3/talin complex which suggests the 
kink straightens when β3 binds to talin.10  The helical conformation positions 
Phe727 and Phe730 on the same face of the β3 helix as residues that interact 
with αIIb (figure 23c and d), consistent with the hypothesis that talin displaces 
αIIb from the β3 cytosolic domain.3 
 
The β3 RGT motif is accessible to Src kinase 
Integrin activation and clustering induces the autophosphorylation of Src kinase 
which initiates intercellular signaling cascades.6  Src constitutively binds the β3 
cytosolic domain and the β3 RGT motif is critical for this interaction.  Although 
most of the β3 cytosolic domain is membrane-embedded and inaccessible to 
cytosolic proteins, the RGT motif is unstructured and should be accessible to Src. 
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CONCLUSION 
The NMR analysis of the disulfide-linked αIIb/β3 construct reveals that stable TM 
interactions are coupled to an intrinsically disordered cytosolic interaction.  This 
structural organization allows the cytosolic domains to integrate many different 
cytosolic events into a binary signal that activates the integrin or maintains its 
resting state. 
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CHAPTER 5 
 
Discussion, Future Direction, and Concluding Remarks 
 
DISCUSSION 
The previous chapters describe the development of software used to model the 
αIIb/β3 TM heterodimer, the verification of the model, and the use of the model to 
engineer an NMR construct that approximates the conformation of the resting 
integrin’s cytosolic domains. Considering first the construction, benchmarking, 
and validation of modeling algorithms, an ideal structure prediction method would 
require only a primary amino acid sequence to accurately calculate a protein’s 
three-dimensional coordinates.  However, as evidenced in the CASP competition, 
currently no method can reliably predict a protein’s structure without additional 
information from empirical analyses.1  Regardless, structure prediction is more of 
an art than a science when it is not supported by experimentation, and so 
prediction and experimentation go hand-in-hand.  In chapter 2, we describe the 
implementation of restraints that enforce calculated differences in energy 
between a wild type model and the same model containing selected point 
mutations in order to provide a selective advantage for conformations that are 
consistent with experimental mutagenesis results.2  While it is unlikely that the 
Monte Carlo algorithm will be employed in additional structure prediction efforts, 
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the energy function and calibration methods provide a framework to implement 
this new type of thermodynamic restraint in next generation protocols. 
Next, chapter 3 provided a quantitative assessment for various models of 
the αIIb/β3 TM heterodimer, and ultimately substantiated the Monte Carlo model.  
This chapter provides strong corroboratory evidence in favor of the interface 
reported in the Monte Carlo model, and recently published NMR and Rosetta 
models likely mark the final global push to determine the αIIb/β3 TM 
heterodimer’s structure with every major player agreeing to the consensus 
model, declaring victory, and elevating the interface from hypothesis to dogma.3; 4  
Still, several features of the αIIb/β3 heterodimer remain unresolved:  First, the β3 
TM domain contains a conserved SXXXA dimerization motif that is not involved 
in the αIIb/β3 interaction (corresponding to a GXXXG dimerization motif in other 
β subunits), and its function has not been discovered.  Second, mutations to αIIb 
Thr981 create a constitutively active state, but its role in stabilizing the resting 
integrin remain unknown.5; 6  Lastly, although the structure of the αIIb GFFKR 
motif converged on similar conformations in both the NMR and Rosetta models,3; 
4 and the orientation of these residues agrees well with experimental results--and 
makes good physiological sense--the interaction between this region of αIIb and 
the β3 membrane proximal, cytosolic domain has not been defined at high-
resolution, and the significance of a possible αIIb Argg995-β3 Asp723 interaction 
remains subject to debate.3; 4 
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The solution structure of the β3 subunit in the disulfide-linked construct 
sheds light on the membrane proximal αIIb/β3 interaction. Our analysis 
demonstrates that the αIIb and β3 cytosolic domains interact and suggests a 
specific interface for β3, consistent with the β3 interface defined by mutagenesis, 
cystiene crosslinking, and multiple NMR models.  In contrast, the literature record 
has not reported a reproducible αIIb interface; instead our results suggest that 
αIIb is natively unstructured, and the αIIb/β3 interface is intrinsically disordered.  
This type of interaction may have evolved to couple multiple different intracellular 
events to the binary resting/active signal relayed by the TM domains.  Lastly, we 
analyzed the structure the β3 cytoslic domain and calculated that helical 
conformations of the talin and kindlin-3 binding sites partition into the membrane, 
a topology that is inaccessible to either protein.  Thus the binding of talin or 
kindlin-3 would trap the β3 cytosolic domain in an exposed conformation, 
providing a mechanism for conformational change that could shift the integrin 
equilibrium toward an active state. 
 
In conclusion, this thesis describes three-dimensional structures for the αIIb/β3 
TM and cytosolic heterodimer.  These models corroborate experimentally defined 
αIIb/β3 interfaces and provide a foundation for new, testable hypotheses that 
back avant-garde mechanisms of integrin activation. 
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